Daren13 personal page - To The Moon

Daren13

No personal profile

2Follow

0Followers

0Topic

0Badge

2021-06-14

To the moon

Sorry, the original content has been removed

2021-06-14

Great ariticle, would you like to share it?

Mudrick’s AMC Bet Backfires After Meme Frenzy Wrecks Hedges

2021-06-14

Great ariticle, would you like to share it?

Don't be fooled by some of the hawkish sounds coming out of the Fed next week

2021-06-14

Great ariticle, would you like to share it?

Wannabe Bitcoin ETFs Are Mushrooming and Getting More Creative

2021-06-14

Good

Sorry, the original content has been removed

2021-06-14

Good

Vietnam approves Pfizer/BioNTech COVID-19 vaccine for emergency use

2021-06-13

Wow

Biotech Finds Market Love at Last as Meme Traders, FDA Converge

2021-06-13

Great ariticle, would you like to share it?

Why direct indexing is gaining traction with financial advisers and their clients

2021-06-13

Great ariticle, would you like to share it?

Why direct indexing is gaining traction with financial advisers and their clients

2021-06-13

Great ariticle, would you like to share it?

Snowflake Is a Growth Juggernaut. Wall Street Is Thinking About Stock Value.

2021-06-13

Nice

Sera Prognostics Inc Files For IPO Of Up To $75 Mln Of Class A Common Stock

2021-06-12

Great ariticle, would you like to share it?

Cramer’s week ahead: Don’t underestimate the market’s small gains

2021-06-12

Great ariticle, would you like to share it?

S&P ekes out gains to close languid week

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3569495193201846","uuid":"3569495193201846","gmtCreate":1606402299758,"gmtModify":1606402299758,"name":"Daren13","pinyin":"daren13","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":2,"tweetSize":13,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.09.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":182453087,"gmtCreate":1623600476549,"gmtModify":1704206844463,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"To the moon","listText":"To the moon","text":"To the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/182453087","repostId":"2142202756","repostType":4,"isVote":1,"tweetType":1,"viewCount":325,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182459950,"gmtCreate":1623600433870,"gmtModify":1704206842668,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182459950","repostId":"2142202756","repostType":4,"repost":{"id":"2142202756","pubTimestamp":1623449952,"share":"https://ttm.financial/m/news/2142202756?lang=&edition=fundamental","pubTime":"2021-06-12 06:19","market":"us","language":"en","title":"Mudrick’s AMC Bet Backfires After Meme Frenzy Wrecks Hedges","url":"https://stock-news.laohu8.com/highlight/detail?id=2142202756","media":"Bloomberg","summary":"(Bloomberg) -- After weeks of profiting from the stock and debt of AMC Entertainment Holdings Inc., ","content":"<p>(Bloomberg) -- After weeks of profiting from the stock and debt of AMC Entertainment Holdings Inc., hedge fund Mudrick Capital Management ended up with a 5.4% loss after a derivatives bet went haywire.</p>\n<p>The fund, which specializes in distressed debt, suffered the losses on AMC after day traders pushed the movie theater’s shares up as much as 127% on a single day, derailing call options Mudrick had sold on AMC shares to hedge exposure to the company, according to a person with knowledge of the matter. The Wall Street Journal earlier reported on the losses.</p>\n<p>Up until the improbable surge in AMC’s shares, the firm founded by Jason Mudrick had been among the big winners on AMC securities after the hedge fund agreed to help keep the cinema chain afloat last year by committing to buy new debt issued by the company. That and other AMC positions helped the fund reap almost $200 million in gains in January, Bloomberg News previously reported. Then the firm bought about $230 million of new shares from the company in a deal announced June 1, shares it quickly flipped to day traders and other AMC enthusiasts for another profit.</p>\n<p>But that’s when things started to unravel.</p>\n<p>To protect the firm’s holdings from a market plunge, Mudrick sold call options that gave other investors the right to buy shares from him at pre-set levels -- most of which were at $40 or more -- well above any price at which the shares had ever traded.</p>\n<p>As AMC’s stock surged June 2 in its Reddit-fueled frenzy, the price suddenly blasted past the prices at which the fund’s counterparties could cash in on the call options, the person said. The hedges ended up losing 10%, causing the net loss of 5.4%.</p>\n<p>A representative for Mudrick declined to comment.</p>\n<p><b>Shedding Risk</b></p>\n<p>Mudrick no longer has exposure to AMC after unwinding all of its debt, stock and derivatives bets. The firm is still up between 12% and 14% for the year, the person said.</p>\n<p>A risk committee for Mudrick Capital met virtually on the night of June 1 and decided to exit all debt and derivative positions the following day, the person said. Mudrick sold about a third of its exposure before the stock surged even further on June 2 and was fully out by that afternoon. The firm sold its 15% first-lien bonds in the theater chain for 121 cents on the dollar, the person added.</p>\n<p>But the trade’s unwind didn’t come soon enough. AMC shares surged past $40 to reach as high as $72.62, blowing up the firm’s short position and effectively unraveling what had looked like a winning bet.</p>\n<p>AMC shares have soared more than 2,200% this year, and debt holders have also benefited from the rally. The company’s bonds due 2026 that were trading as low as 5 cents on the dollar in November now change hands above face value, according to Trace.</p>\n<p>While ultimately handing Mudrick a loss, the meme stock frenzy helped AMC earn a credit upgrade from S&amp;P Global Ratings after the company was able to raise hundreds of millions of dollars from share sales.</p>\n<p>Mudrick’s flagship fund rose about 12% in 2020, making much of its money in the fourth quarter of last year, Bloomberg previously reported. The firm manages around $3.5 billion.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mudrick’s AMC Bet Backfires After Meme Frenzy Wrecks Hedges</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMudrick’s AMC Bet Backfires After Meme Frenzy Wrecks Hedges\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 06:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/mudrick-amc-bet-backfires-meme-221912972.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- After weeks of profiting from the stock and debt of AMC Entertainment Holdings Inc., hedge fund Mudrick Capital Management ended up with a 5.4% loss after a derivatives bet went haywire...</p>\n\n<a href=\"https://finance.yahoo.com/news/mudrick-amc-bet-backfires-meme-221912972.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://finance.yahoo.com/news/mudrick-amc-bet-backfires-meme-221912972.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142202756","content_text":"(Bloomberg) -- After weeks of profiting from the stock and debt of AMC Entertainment Holdings Inc., hedge fund Mudrick Capital Management ended up with a 5.4% loss after a derivatives bet went haywire.\nThe fund, which specializes in distressed debt, suffered the losses on AMC after day traders pushed the movie theater’s shares up as much as 127% on a single day, derailing call options Mudrick had sold on AMC shares to hedge exposure to the company, according to a person with knowledge of the matter. The Wall Street Journal earlier reported on the losses.\nUp until the improbable surge in AMC’s shares, the firm founded by Jason Mudrick had been among the big winners on AMC securities after the hedge fund agreed to help keep the cinema chain afloat last year by committing to buy new debt issued by the company. That and other AMC positions helped the fund reap almost $200 million in gains in January, Bloomberg News previously reported. Then the firm bought about $230 million of new shares from the company in a deal announced June 1, shares it quickly flipped to day traders and other AMC enthusiasts for another profit.\nBut that’s when things started to unravel.\nTo protect the firm’s holdings from a market plunge, Mudrick sold call options that gave other investors the right to buy shares from him at pre-set levels -- most of which were at $40 or more -- well above any price at which the shares had ever traded.\nAs AMC’s stock surged June 2 in its Reddit-fueled frenzy, the price suddenly blasted past the prices at which the fund’s counterparties could cash in on the call options, the person said. The hedges ended up losing 10%, causing the net loss of 5.4%.\nA representative for Mudrick declined to comment.\nShedding Risk\nMudrick no longer has exposure to AMC after unwinding all of its debt, stock and derivatives bets. The firm is still up between 12% and 14% for the year, the person said.\nA risk committee for Mudrick Capital met virtually on the night of June 1 and decided to exit all debt and derivative positions the following day, the person said. Mudrick sold about a third of its exposure before the stock surged even further on June 2 and was fully out by that afternoon. The firm sold its 15% first-lien bonds in the theater chain for 121 cents on the dollar, the person added.\nBut the trade’s unwind didn’t come soon enough. AMC shares surged past $40 to reach as high as $72.62, blowing up the firm’s short position and effectively unraveling what had looked like a winning bet.\nAMC shares have soared more than 2,200% this year, and debt holders have also benefited from the rally. The company’s bonds due 2026 that were trading as low as 5 cents on the dollar in November now change hands above face value, according to Trace.\nWhile ultimately handing Mudrick a loss, the meme stock frenzy helped AMC earn a credit upgrade from S&P Global Ratings after the company was able to raise hundreds of millions of dollars from share sales.\nMudrick’s flagship fund rose about 12% in 2020, making much of its money in the fourth quarter of last year, Bloomberg previously reported. The firm manages around $3.5 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182427380,"gmtCreate":1623600335040,"gmtModify":1704206841526,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182427380","repostId":"2142858202","repostType":4,"repost":{"id":"2142858202","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623453060,"share":"https://ttm.financial/m/news/2142858202?lang=&edition=fundamental","pubTime":"2021-06-12 07:11","market":"us","language":"en","title":"Don't be fooled by some of the hawkish sounds coming out of the Fed next week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142858202","media":"Dow Jones","summary":"Fed will remain dovish, economists say.\n\nThere are sixteen different types of hawks found in the Uni","content":"<blockquote>\n Fed will remain dovish, economists say.\n</blockquote>\n<p>There are sixteen different types of hawks found in the United States, according to birdwatchingh.com . While it may be tempting, it is too soon to add Federal Reserve policymakers to that list.</p>\n<p>Much will be made next week out of some potentially \"hawkish\" sounds from the U.S. central bank's policy meeting, economists said, while they stressed that Fed Chairman Jerome Powell and the majority of the voting members of the interest rate setting committee remain \"doves\" and fundamentally will be sticking to their \"patient\" stance on monetary policy.</p>\n<p>\"They are going to be a little bit less dovish than last time,\" said Jim O'Sullivan, chief U.S. macro strategist for TD Securities.</p>\n<p>U.S. inflation has been sizzling in recent months.</p>\n<p>But the recent decline in long-term Treasury yields allows the Fed to lean into the hawkish message, O'Sullivan said.</p>\n<p>While inflation has been surprisingly hot, the Fed \"is willing to wait\" until the fall to see how the labor market responds to the inflation spike, said Ian Shepherdson, chief economist at Pantheon Macroeconomics. Wage pressures play a key role in determining the inflation outlook.</p>\n<p>\"We don't know how many people will come back into the labor market, how participation will rise, and will it be enough to dampen inflationary pressures,\" Shepherdson said.</p>\n<p>\"In the olden days, the Fed would have raised interest rates first and worried about what was going to happen afterwards. But this is a different Fed with a different strategy and a different approach,\" he said.</p>\n<p>The Fed is buying $80 billion of Treasurys and $40 billion of mortgage backed securities each month, along with keeping its benchmark interest rate close to zero, to support the economy.</p>\n<p>The central bank put itself in a bit of a box in December by guiding markets that it wouldn't slow down the pace of purchases until there had been \"substantial further progress\" in its goals of full employment and stable inflation.</p>\n<p><b>What will be the hawkish sounds?</b></p>\n<p>First, the Fed will give in to the reality that talking about tapering the size of its asset purchases makes sense. This is an important shift. Since December, Powell has managed to hold off such talk.</p>\n<p>But this is only the most preliminary of steps.</p>\n<p>Instead \"officials will talk in general straw-poll terms on what principles ought to apply,\" said Lou Crandall, chief economist at Wrightson ICAP.</p>\n<p>It won't be the Fed having a structured debate on a set of options game-planned by the staff. That might happen in July, but not now.</p>\n<p>To downplay the significance, the Fed won't say anything about the \"talks about tapering\" in its formal statement, next Wednesday afternoon, O'Sullivan said.</p>\n<p>Secondly, the Fed's dot-plot, or interest rate forecast chart, may show a shift forward for the first rate hike to come during 2023. At the moment, the Fed shows no rate hikes until 2024 at the earliest.</p>\n<p>At its March meeting, seven out of 18 Fed officials saw a hike before the end of 2023, and it could be nine or ten officials at the June meeting next week.</p>\n<p>Thirdly, the Fed will have to raise its forecast for inflation for this year. In March, the Fed penciled in a 2.2% core rate for the personal consumption expenditure index. While that may rise, the Fed won't move the core rate for 2022 much higher, a signal that it still believes the price gains seen in the last few months reflects \"largely transitory\" factors.</p>\n<p>During press conferences, Powell has said the economy is \"a long way\" from the Fed's goals and it would take \"some time\" for substantial further progress to be achieved.</p>\n<p>\"I wouldn't pound the table and say exactly what Powell is going to say but it is time to start getting away from that language,\" O'Sullivan of TD Securities said.</p>\n<p>At the same time, the Fed has got to say that while the economy has made progress, they still need to see a lot more,\" he added.</p>\n<p>When the Fed added the \"substantial further progress\" guideline, the economy was 9.8 million jobs short of its level in February 2020. At the moment, the economy is 7.6 million jobs short.</p>\n<p>None of these potentially hawkish noises will disturb the central message of Fed officials to the market -- that its benchmark interest rate will stay low next year.</p>\n<p>Even if the Fed starts to taper its asset purchases next January, economists think it will take months before the central bank is ready to take the next step and hike its benchmark interest rates off zero.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Don't be fooled by some of the hawkish sounds coming out of the Fed next week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDon't be fooled by some of the hawkish sounds coming out of the Fed next week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-12 07:11</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n Fed will remain dovish, economists say.\n</blockquote>\n<p>There are sixteen different types of hawks found in the United States, according to birdwatchingh.com . While it may be tempting, it is too soon to add Federal Reserve policymakers to that list.</p>\n<p>Much will be made next week out of some potentially \"hawkish\" sounds from the U.S. central bank's policy meeting, economists said, while they stressed that Fed Chairman Jerome Powell and the majority of the voting members of the interest rate setting committee remain \"doves\" and fundamentally will be sticking to their \"patient\" stance on monetary policy.</p>\n<p>\"They are going to be a little bit less dovish than last time,\" said Jim O'Sullivan, chief U.S. macro strategist for TD Securities.</p>\n<p>U.S. inflation has been sizzling in recent months.</p>\n<p>But the recent decline in long-term Treasury yields allows the Fed to lean into the hawkish message, O'Sullivan said.</p>\n<p>While inflation has been surprisingly hot, the Fed \"is willing to wait\" until the fall to see how the labor market responds to the inflation spike, said Ian Shepherdson, chief economist at Pantheon Macroeconomics. Wage pressures play a key role in determining the inflation outlook.</p>\n<p>\"We don't know how many people will come back into the labor market, how participation will rise, and will it be enough to dampen inflationary pressures,\" Shepherdson said.</p>\n<p>\"In the olden days, the Fed would have raised interest rates first and worried about what was going to happen afterwards. But this is a different Fed with a different strategy and a different approach,\" he said.</p>\n<p>The Fed is buying $80 billion of Treasurys and $40 billion of mortgage backed securities each month, along with keeping its benchmark interest rate close to zero, to support the economy.</p>\n<p>The central bank put itself in a bit of a box in December by guiding markets that it wouldn't slow down the pace of purchases until there had been \"substantial further progress\" in its goals of full employment and stable inflation.</p>\n<p><b>What will be the hawkish sounds?</b></p>\n<p>First, the Fed will give in to the reality that talking about tapering the size of its asset purchases makes sense. This is an important shift. Since December, Powell has managed to hold off such talk.</p>\n<p>But this is only the most preliminary of steps.</p>\n<p>Instead \"officials will talk in general straw-poll terms on what principles ought to apply,\" said Lou Crandall, chief economist at Wrightson ICAP.</p>\n<p>It won't be the Fed having a structured debate on a set of options game-planned by the staff. That might happen in July, but not now.</p>\n<p>To downplay the significance, the Fed won't say anything about the \"talks about tapering\" in its formal statement, next Wednesday afternoon, O'Sullivan said.</p>\n<p>Secondly, the Fed's dot-plot, or interest rate forecast chart, may show a shift forward for the first rate hike to come during 2023. At the moment, the Fed shows no rate hikes until 2024 at the earliest.</p>\n<p>At its March meeting, seven out of 18 Fed officials saw a hike before the end of 2023, and it could be nine or ten officials at the June meeting next week.</p>\n<p>Thirdly, the Fed will have to raise its forecast for inflation for this year. In March, the Fed penciled in a 2.2% core rate for the personal consumption expenditure index. While that may rise, the Fed won't move the core rate for 2022 much higher, a signal that it still believes the price gains seen in the last few months reflects \"largely transitory\" factors.</p>\n<p>During press conferences, Powell has said the economy is \"a long way\" from the Fed's goals and it would take \"some time\" for substantial further progress to be achieved.</p>\n<p>\"I wouldn't pound the table and say exactly what Powell is going to say but it is time to start getting away from that language,\" O'Sullivan of TD Securities said.</p>\n<p>At the same time, the Fed has got to say that while the economy has made progress, they still need to see a lot more,\" he added.</p>\n<p>When the Fed added the \"substantial further progress\" guideline, the economy was 9.8 million jobs short of its level in February 2020. At the moment, the economy is 7.6 million jobs short.</p>\n<p>None of these potentially hawkish noises will disturb the central message of Fed officials to the market -- that its benchmark interest rate will stay low next year.</p>\n<p>Even if the Fed starts to taper its asset purchases next January, economists think it will take months before the central bank is ready to take the next step and hike its benchmark interest rates off zero.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142858202","content_text":"Fed will remain dovish, economists say.\n\nThere are sixteen different types of hawks found in the United States, according to birdwatchingh.com . While it may be tempting, it is too soon to add Federal Reserve policymakers to that list.\nMuch will be made next week out of some potentially \"hawkish\" sounds from the U.S. central bank's policy meeting, economists said, while they stressed that Fed Chairman Jerome Powell and the majority of the voting members of the interest rate setting committee remain \"doves\" and fundamentally will be sticking to their \"patient\" stance on monetary policy.\n\"They are going to be a little bit less dovish than last time,\" said Jim O'Sullivan, chief U.S. macro strategist for TD Securities.\nU.S. inflation has been sizzling in recent months.\nBut the recent decline in long-term Treasury yields allows the Fed to lean into the hawkish message, O'Sullivan said.\nWhile inflation has been surprisingly hot, the Fed \"is willing to wait\" until the fall to see how the labor market responds to the inflation spike, said Ian Shepherdson, chief economist at Pantheon Macroeconomics. Wage pressures play a key role in determining the inflation outlook.\n\"We don't know how many people will come back into the labor market, how participation will rise, and will it be enough to dampen inflationary pressures,\" Shepherdson said.\n\"In the olden days, the Fed would have raised interest rates first and worried about what was going to happen afterwards. But this is a different Fed with a different strategy and a different approach,\" he said.\nThe Fed is buying $80 billion of Treasurys and $40 billion of mortgage backed securities each month, along with keeping its benchmark interest rate close to zero, to support the economy.\nThe central bank put itself in a bit of a box in December by guiding markets that it wouldn't slow down the pace of purchases until there had been \"substantial further progress\" in its goals of full employment and stable inflation.\nWhat will be the hawkish sounds?\nFirst, the Fed will give in to the reality that talking about tapering the size of its asset purchases makes sense. This is an important shift. Since December, Powell has managed to hold off such talk.\nBut this is only the most preliminary of steps.\nInstead \"officials will talk in general straw-poll terms on what principles ought to apply,\" said Lou Crandall, chief economist at Wrightson ICAP.\nIt won't be the Fed having a structured debate on a set of options game-planned by the staff. That might happen in July, but not now.\nTo downplay the significance, the Fed won't say anything about the \"talks about tapering\" in its formal statement, next Wednesday afternoon, O'Sullivan said.\nSecondly, the Fed's dot-plot, or interest rate forecast chart, may show a shift forward for the first rate hike to come during 2023. At the moment, the Fed shows no rate hikes until 2024 at the earliest.\nAt its March meeting, seven out of 18 Fed officials saw a hike before the end of 2023, and it could be nine or ten officials at the June meeting next week.\nThirdly, the Fed will have to raise its forecast for inflation for this year. In March, the Fed penciled in a 2.2% core rate for the personal consumption expenditure index. While that may rise, the Fed won't move the core rate for 2022 much higher, a signal that it still believes the price gains seen in the last few months reflects \"largely transitory\" factors.\nDuring press conferences, Powell has said the economy is \"a long way\" from the Fed's goals and it would take \"some time\" for substantial further progress to be achieved.\n\"I wouldn't pound the table and say exactly what Powell is going to say but it is time to start getting away from that language,\" O'Sullivan of TD Securities said.\nAt the same time, the Fed has got to say that while the economy has made progress, they still need to see a lot more,\" he added.\nWhen the Fed added the \"substantial further progress\" guideline, the economy was 9.8 million jobs short of its level in February 2020. At the moment, the economy is 7.6 million jobs short.\nNone of these potentially hawkish noises will disturb the central message of Fed officials to the market -- that its benchmark interest rate will stay low next year.\nEven if the Fed starts to taper its asset purchases next January, economists think it will take months before the central bank is ready to take the next step and hike its benchmark interest rates off zero.","news_type":1},"isVote":1,"tweetType":1,"viewCount":87,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182424533,"gmtCreate":1623600317322,"gmtModify":1704206840875,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182424533","repostId":"2142878860","repostType":4,"repost":{"id":"2142878860","pubTimestamp":1623502800,"share":"https://ttm.financial/m/news/2142878860?lang=&edition=fundamental","pubTime":"2021-06-12 21:00","market":"us","language":"en","title":"Wannabe Bitcoin ETFs Are Mushrooming and Getting More Creative","url":"https://stock-news.laohu8.com/highlight/detail?id=2142878860","media":"Bloomberg","summary":"(Bloomberg) -- With at least nine applications for Bitcoins ETFs collecting dust in the Securities a","content":"<p><img src=\"https://static.tigerbbs.com/df0e27ba0805faa81349dcd8279cd9d0\" tg-width=\"1200\" tg-height=\"675\"></p>\n<p>(Bloomberg) -- With at least nine applications for Bitcoins ETFs collecting dust in the Securities and Exchange Commission’s in-box and clients baying to buy crypto funds, U.S. issuers in the $6.4 trillion industry are cobbling together a growing number of workarounds.</p>\n<p>A slate of companies are releasing or planning “Bitcoin adjacent” products that skirt U.S. regulators’ refusal to allow the largest cryptocurrency to be put in an exchange-traded fund wrapper. Invesco became the latest on Wednesday, announcing a pair of funds packed with crypto-linked equities.</p>\n<p>It’s the only way U.S. firms can cash in on the unrelenting clamor for digital coins, and it may stay that way for a while. The SEC has already delayed its decision to approve or deny a Bitcoin ETF once this year and is expected to punt again at its next deadline on June 17.</p>\n<p>“There’s clearly strong demand from investors for exposure to the price of Bitcoin, and ETF issuers are simply looking to meet that demand,” said Nate Geraci, president of the ETF Store, an advisory firm. “The SEC is essentially forcing ETF issuers into the laboratory to create these Frankenstein products.”</p>\n<p>The Frankenfunds’ creators are being rewarded for their efforts. For instance, the Bitwise Crypto Industry Innovators ETF (ticker BITQ) has already drawn about $45 million in assets less than a month after its launch. That fund holds crypto-heavy companies like MicroStrategy Inc., Coinbase Global Inc., and Galaxy Digital Holdings Ltd.</p>\n<p>Then there’s a slate of older products finding new life amid the coin craze. The <a href=\"https://laohu8.com/S/BLOK\">Amplify Transformational Data Sharing ETF</a> (BLOK), an actively-managed fund with stocks like MicroStrategy and <a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings Inc., attracted more than $711 million this year already, as its price has risen 30%. A peer fund called the First Trust Indxx Innovative Transaction &amp; Process ETF (LEGR), which invests in companies using or developing blockchain technology, is on pace for its best year of inflows yet.</p>\n<p>“There is a high demand for a Bitcoin product that has all the features that people love about ETFs -- that they trade on an exchange, that they’re liquid,” said Ross Mayfield, investment strategy analyst at Robert W. Baird &amp; Co.</p>\n<p><b>Biggest Player Yet</b></p>\n<p>Invesco is the largest fund manager yet to try the workaround tactic, with its Invesco Galaxy Blockchain Economy ETF and Invesco Galaxy Crypto Economy ETF, each holding about 85% of their assets in crypto-linked equities and the rest in trusts and funds that hold cryptocurrencies.</p>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> days before the Invesco filing, there was an application for the Volt Bitcoin Revolution ETF, which would include companies with Bitcoin exposure. At least 80% of its assets will be in firms that either have Bitcoin on their balance sheet or are developing or using products within the crypto ecosystem, as well as options on those firms and ETFs that have exposure to them.</p>\n<p>More funds tracking the crypto industry -- instead of actual Bitcoin -- may debut in the coming months, as the SEC continues to voice concerns about the market. Recently, SEC Chairman Gary Gensler said the crypto sector could benefit from greater investor protection and has urged Congress to give the regulatory agency authority over trading venues.</p>\n<p>“My optimism on Bitcoin ETF approval has waned recently,” ETF Store’s Geraci said. “It’s hard to view Gensler’s comments on the current state of the Bitcoin and crypto ecosystem and feel optimistic about the prospects of a Bitcoin ETF anytime soon.”</p>\n<p>Even after a true Bitcoin ETF finally launches in U.S. markets, these crypto-flavored funds could still have appeal, especially in a world obsessed with all things involving blockchain and digital tokens.</p>\n<p>“These Bitcoin-adjacent vehicles make sense for people who don’t want to deal with all the volatility of Bitcoin but want exposure,” said Amrita Nandakumar, president of Vident Investment Advisory. “It’s a solution that has popped up in response to the pent-up demand.”</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wannabe Bitcoin ETFs Are Mushrooming and Getting More Creative</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWannabe Bitcoin ETFs Are Mushrooming and Getting More Creative\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 21:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/wannabe-bitcoin-etfs-mushrooming-getting-130000561.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- With at least nine applications for Bitcoins ETFs collecting dust in the Securities and Exchange Commission’s in-box and clients baying to buy crypto funds, U.S. issuers in the $6.4 ...</p>\n\n<a href=\"https://finance.yahoo.com/news/wannabe-bitcoin-etfs-mushrooming-getting-130000561.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IVZ":"美国景顺集团"},"source_url":"https://finance.yahoo.com/news/wannabe-bitcoin-etfs-mushrooming-getting-130000561.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142878860","content_text":"(Bloomberg) -- With at least nine applications for Bitcoins ETFs collecting dust in the Securities and Exchange Commission’s in-box and clients baying to buy crypto funds, U.S. issuers in the $6.4 trillion industry are cobbling together a growing number of workarounds.\nA slate of companies are releasing or planning “Bitcoin adjacent” products that skirt U.S. regulators’ refusal to allow the largest cryptocurrency to be put in an exchange-traded fund wrapper. Invesco became the latest on Wednesday, announcing a pair of funds packed with crypto-linked equities.\nIt’s the only way U.S. firms can cash in on the unrelenting clamor for digital coins, and it may stay that way for a while. The SEC has already delayed its decision to approve or deny a Bitcoin ETF once this year and is expected to punt again at its next deadline on June 17.\n“There’s clearly strong demand from investors for exposure to the price of Bitcoin, and ETF issuers are simply looking to meet that demand,” said Nate Geraci, president of the ETF Store, an advisory firm. “The SEC is essentially forcing ETF issuers into the laboratory to create these Frankenstein products.”\nThe Frankenfunds’ creators are being rewarded for their efforts. For instance, the Bitwise Crypto Industry Innovators ETF (ticker BITQ) has already drawn about $45 million in assets less than a month after its launch. That fund holds crypto-heavy companies like MicroStrategy Inc., Coinbase Global Inc., and Galaxy Digital Holdings Ltd.\nThen there’s a slate of older products finding new life amid the coin craze. The Amplify Transformational Data Sharing ETF (BLOK), an actively-managed fund with stocks like MicroStrategy and PayPal Holdings Inc., attracted more than $711 million this year already, as its price has risen 30%. A peer fund called the First Trust Indxx Innovative Transaction & Process ETF (LEGR), which invests in companies using or developing blockchain technology, is on pace for its best year of inflows yet.\n“There is a high demand for a Bitcoin product that has all the features that people love about ETFs -- that they trade on an exchange, that they’re liquid,” said Ross Mayfield, investment strategy analyst at Robert W. Baird & Co.\nBiggest Player Yet\nInvesco is the largest fund manager yet to try the workaround tactic, with its Invesco Galaxy Blockchain Economy ETF and Invesco Galaxy Crypto Economy ETF, each holding about 85% of their assets in crypto-linked equities and the rest in trusts and funds that hold cryptocurrencies.\nTwo days before the Invesco filing, there was an application for the Volt Bitcoin Revolution ETF, which would include companies with Bitcoin exposure. At least 80% of its assets will be in firms that either have Bitcoin on their balance sheet or are developing or using products within the crypto ecosystem, as well as options on those firms and ETFs that have exposure to them.\nMore funds tracking the crypto industry -- instead of actual Bitcoin -- may debut in the coming months, as the SEC continues to voice concerns about the market. Recently, SEC Chairman Gary Gensler said the crypto sector could benefit from greater investor protection and has urged Congress to give the regulatory agency authority over trading venues.\n“My optimism on Bitcoin ETF approval has waned recently,” ETF Store’s Geraci said. “It’s hard to view Gensler’s comments on the current state of the Bitcoin and crypto ecosystem and feel optimistic about the prospects of a Bitcoin ETF anytime soon.”\nEven after a true Bitcoin ETF finally launches in U.S. markets, these crypto-flavored funds could still have appeal, especially in a world obsessed with all things involving blockchain and digital tokens.\n“These Bitcoin-adjacent vehicles make sense for people who don’t want to deal with all the volatility of Bitcoin but want exposure,” said Amrita Nandakumar, president of Vident Investment Advisory. “It’s a solution that has popped up in response to the pent-up demand.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":149,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182424356,"gmtCreate":1623600300175,"gmtModify":1704206840188,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182424356","repostId":"2142878860","repostType":4,"isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182426674,"gmtCreate":1623600210498,"gmtModify":1704206837420,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182426674","repostId":"2142788912","repostType":4,"repost":{"id":"2142788912","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623507814,"share":"https://ttm.financial/m/news/2142788912?lang=&edition=fundamental","pubTime":"2021-06-12 22:23","market":"us","language":"en","title":"Vietnam approves Pfizer/BioNTech COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142788912","media":"Reuters","summary":"HANOI, June 12  - Vietnam has approved the COVID-19 vaccine jointly made by Pfizer and BioNTech for domestic emergency use, the government said on Saturday.It is the fourth vaccine to be endorsed in the Southeast Asian country that is tackling a new outbreak.Vietnam, which has previously approved the AstraZeneca vaccine, Russia's Sputnik V and China's Sinopharm vaccine, said it is seeking to procure 31 million doses of the Pfizer/BioNTech version for delivery in the next quarter.Vietnam is tryin","content":"<p>HANOI, June 12 (Reuters) - Vietnam has approved the COVID-19 vaccine jointly made by Pfizer and BioNTech for domestic emergency use, the government said on Saturday.</p>\n<p>It is the fourth vaccine to be endorsed in the Southeast Asian country that is tackling a new outbreak.</p>\n<p>Vietnam, which has previously approved the AstraZeneca vaccine, Russia's Sputnik V and China's Sinopharm vaccine, said it is seeking to procure 31 million doses of the Pfizer/BioNTech version for delivery in the next quarter.</p>\n<p>Vietnam is trying to accelerate its vaccine procurement drive to tackle a more stubborn wave of infections, even though its overall case load and fatality numbers remain relatively low.</p>\n<p>The health ministry also said on Saturday it was in talks with an unidentified U.S. manufacturer to producer a <a href=\"https://laohu8.com/S/AONE\">one</a>-dose vaccine with a view to producing 100 million-200 million shots per year.</p>\n<p>Vietnam, with a population of around 98 million, has recorded a total of 10,241 coronavirus cases, with 58 deaths, since the pandemic began. Its domestic inoculation started in March.</p>\n<p>At least 1.4 million people in Vietnam have had <a href=\"https://laohu8.com/S/AONE.U\">one</a> dose of a COVID-19 vaccine, while 53,127 have been fully vaccinated, according to official data.</p>\n<p>(Reporting by Phuong Nguyen; Editing by Toby Chopra and Mike Harrison)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vietnam approves Pfizer/BioNTech COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVietnam approves Pfizer/BioNTech COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 22:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HANOI, June 12 (Reuters) - Vietnam has approved the COVID-19 vaccine jointly made by Pfizer and BioNTech for domestic emergency use, the government said on Saturday.</p>\n<p>It is the fourth vaccine to be endorsed in the Southeast Asian country that is tackling a new outbreak.</p>\n<p>Vietnam, which has previously approved the AstraZeneca vaccine, Russia's Sputnik V and China's Sinopharm vaccine, said it is seeking to procure 31 million doses of the Pfizer/BioNTech version for delivery in the next quarter.</p>\n<p>Vietnam is trying to accelerate its vaccine procurement drive to tackle a more stubborn wave of infections, even though its overall case load and fatality numbers remain relatively low.</p>\n<p>The health ministry also said on Saturday it was in talks with an unidentified U.S. manufacturer to producer a <a href=\"https://laohu8.com/S/AONE\">one</a>-dose vaccine with a view to producing 100 million-200 million shots per year.</p>\n<p>Vietnam, with a population of around 98 million, has recorded a total of 10,241 coronavirus cases, with 58 deaths, since the pandemic began. Its domestic inoculation started in March.</p>\n<p>At least 1.4 million people in Vietnam have had <a href=\"https://laohu8.com/S/AONE.U\">one</a> dose of a COVID-19 vaccine, while 53,127 have been fully vaccinated, according to official data.</p>\n<p>(Reporting by Phuong Nguyen; Editing by Toby Chopra and Mike Harrison)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142788912","content_text":"HANOI, June 12 (Reuters) - Vietnam has approved the COVID-19 vaccine jointly made by Pfizer and BioNTech for domestic emergency use, the government said on Saturday.\nIt is the fourth vaccine to be endorsed in the Southeast Asian country that is tackling a new outbreak.\nVietnam, which has previously approved the AstraZeneca vaccine, Russia's Sputnik V and China's Sinopharm vaccine, said it is seeking to procure 31 million doses of the Pfizer/BioNTech version for delivery in the next quarter.\nVietnam is trying to accelerate its vaccine procurement drive to tackle a more stubborn wave of infections, even though its overall case load and fatality numbers remain relatively low.\nThe health ministry also said on Saturday it was in talks with an unidentified U.S. manufacturer to producer a one-dose vaccine with a view to producing 100 million-200 million shots per year.\nVietnam, with a population of around 98 million, has recorded a total of 10,241 coronavirus cases, with 58 deaths, since the pandemic began. Its domestic inoculation started in March.\nAt least 1.4 million people in Vietnam have had one dose of a COVID-19 vaccine, while 53,127 have been fully vaccinated, according to official data.\n(Reporting by Phuong Nguyen; Editing by Toby Chopra and Mike Harrison)","news_type":1},"isVote":1,"tweetType":1,"viewCount":70,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186491960,"gmtCreate":1623516908550,"gmtModify":1704205418769,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186491960","repostId":"2142025622","repostType":4,"repost":{"id":"2142025622","pubTimestamp":1623442528,"share":"https://ttm.financial/m/news/2142025622?lang=&edition=fundamental","pubTime":"2021-06-12 04:15","market":"us","language":"en","title":"Biotech Finds Market Love at Last as Meme Traders, FDA Converge","url":"https://stock-news.laohu8.com/highlight/detail?id=2142025622","media":"Bloomberg","summary":"(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial","content":"<p><img src=\"https://static.tigerbbs.com/8cda5e1416d8765a6009019a2442b35a\" tg-width=\"1200\" tg-height=\"675\"></p>\n<p>(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial regulatory decision and a legion of Reddit fans, burning a bunch of short sellers along the way. Now investors are taking a second look at the sector.</p>\n<p>With biotech having trailed the broader market for the past three months and chock full of companies that have been the focus of short sellers, it was catnip for the Reddit crowd. Indeed, the price action wrought havoc across the health-care sector after shorts lost over $465 million on Clover Health Investments Corp. in a single day as the stock nearly doubled.</p>\n<p>The moves weren’t just about amateur traders or punishing the shorts. Specialists who live and breathe biotech received two of three critical updates that have been hailed as the impetus for a broad return of investor interest. That includes approval from the Food and Drug Administration of an Alzheimer’s disease drug from Biogen Inc.</p>\n<p>“One of the clouds overhanging the sector went away this week, it’s a very good sign,” Brad Loncar, chief executive officer of Loncar Investments, said of the FDA decision.</p>\n<p>Monday’s decision by the FDA to approve Aduhelm, the first new medicine for the disease in decades, came despite mixed clinical trials, stunning analysts and buoying the sector. More than 15 million shares in the $11 billion <a href=\"https://laohu8.com/S/EEME\">iShares</a> Nasdaq Biotechnology ETF (IBB) changed hands, the highest daily level since June 2017. The index ended the week up 6%.</p>\n<p>It wasn’t all good news for these drugmakers. Aduhelm’s $56,000 a year price tag and a setback for Vertex Pharmaceuticals Inc. tempered the rally. The cost of the Biogen drug renewed concern about a regulatory clampdown on pricing, while Vertex announced that it had halted development of a liver disease treatment that the company said was unlikely to have a clinical benefit for patients. Shares of the drug developer plunged 11% on Friday and it’s the worst performer among large-cap biotechs, falling 18% so far this year.</p>\n<p>There’s <a href=\"https://laohu8.com/S/AONE\">one</a> more key readout biotech investors are waiting on: results from a trial in major depression from Biogen and its partner <a href=\"https://laohu8.com/S/SAGE\">Sage Therapeutics</a> Inc. With a win for Biogen and a loss for Vertex, the Biogen-Sage results could very well determine which direction biotech goes next, according to RBC analyst Brian Abrahams. The data are expected by the end of June.</p>\n<p>A recent Goldman Sachs survey of 75 investors at the bank’s health-care conference highlights the ongoing uncertainty, with 47% saying the sector would outperform over the second half of the year while the rest were evenly split between expecting health stocks to underperform or move in-line with the broader market.</p>\n<p><b>M&amp;A Hopes</b></p>\n<p>Vertex’s recent failure also came with a silver lining: the potential for a deal to bolster its pipeline. “Management has signaled a new openness to later-stage deals, and the shelving of VX-864 may now force its hand,” Bloomberg Intelligence analyst Marc Engelsgjerd wrote in a note.</p>\n<p>The pace of deals in the first half can determine the direction of biotechs for the rest of 2021, with years that start off with five or more deals over $500 million usually driving the outperformance of nearly 4% for the Nasdaq Biotech index, according to JPMorgan’s analysis.</p>\n<p>As biotech specialists weighed the catalysts for further gains, an 86% jump for Chamath Palihapitiya-backed health insurer Clover drove interest toward once high-flying biotechs with highly shorted floats and mediocre analyst ratings. <a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals Inc</a>., which recently lost U.S. government funding for its Covid shot, and <a href=\"https://laohu8.com/S/CLVS\">Clovis Oncology</a> Inc., a fallen former M&amp;A target with a disappointing cancer drug, popped this week as day traders targeted short-squeeze candidates.</p>\n<p>Retail traders have also been driving triple-digit and even quadruple-digit gains in obscure biotech names like Ocugen Inc., a drug developer with plans to bring a Covid-19 vaccine to the U.S., and <a href=\"https://laohu8.com/S/SAVA\">Cassava Sciences Inc</a>., a 20-year old biotech whose main product isn’t yet in the final stages of testing.</p>\n<p>Loncar at least is unfazed by biotechs joining the meme parade. “Professionals understand what the true intrinsic value of a biotech is,” he said in an interview. “Unlike GameStop or AMC, a biotech either has good science or it doesn’t.”</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biotech Finds Market Love at Last as Meme Traders, FDA Converge</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiotech Finds Market Love at Last as Meme Traders, FDA Converge\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 04:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/biotech-finds-market-love-last-201528495.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial regulatory decision and a legion of Reddit fans, burning a bunch of short sellers along the way. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/biotech-finds-market-love-last-201528495.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRTX":"福泰制药","BIIB":"渤健公司"},"source_url":"https://finance.yahoo.com/news/biotech-finds-market-love-last-201528495.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142025622","content_text":"(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial regulatory decision and a legion of Reddit fans, burning a bunch of short sellers along the way. Now investors are taking a second look at the sector.\nWith biotech having trailed the broader market for the past three months and chock full of companies that have been the focus of short sellers, it was catnip for the Reddit crowd. Indeed, the price action wrought havoc across the health-care sector after shorts lost over $465 million on Clover Health Investments Corp. in a single day as the stock nearly doubled.\nThe moves weren’t just about amateur traders or punishing the shorts. Specialists who live and breathe biotech received two of three critical updates that have been hailed as the impetus for a broad return of investor interest. That includes approval from the Food and Drug Administration of an Alzheimer’s disease drug from Biogen Inc.\n“One of the clouds overhanging the sector went away this week, it’s a very good sign,” Brad Loncar, chief executive officer of Loncar Investments, said of the FDA decision.\nMonday’s decision by the FDA to approve Aduhelm, the first new medicine for the disease in decades, came despite mixed clinical trials, stunning analysts and buoying the sector. More than 15 million shares in the $11 billion iShares Nasdaq Biotechnology ETF (IBB) changed hands, the highest daily level since June 2017. The index ended the week up 6%.\nIt wasn’t all good news for these drugmakers. Aduhelm’s $56,000 a year price tag and a setback for Vertex Pharmaceuticals Inc. tempered the rally. The cost of the Biogen drug renewed concern about a regulatory clampdown on pricing, while Vertex announced that it had halted development of a liver disease treatment that the company said was unlikely to have a clinical benefit for patients. Shares of the drug developer plunged 11% on Friday and it’s the worst performer among large-cap biotechs, falling 18% so far this year.\nThere’s one more key readout biotech investors are waiting on: results from a trial in major depression from Biogen and its partner Sage Therapeutics Inc. With a win for Biogen and a loss for Vertex, the Biogen-Sage results could very well determine which direction biotech goes next, according to RBC analyst Brian Abrahams. The data are expected by the end of June.\nA recent Goldman Sachs survey of 75 investors at the bank’s health-care conference highlights the ongoing uncertainty, with 47% saying the sector would outperform over the second half of the year while the rest were evenly split between expecting health stocks to underperform or move in-line with the broader market.\nM&A Hopes\nVertex’s recent failure also came with a silver lining: the potential for a deal to bolster its pipeline. “Management has signaled a new openness to later-stage deals, and the shelving of VX-864 may now force its hand,” Bloomberg Intelligence analyst Marc Engelsgjerd wrote in a note.\nThe pace of deals in the first half can determine the direction of biotechs for the rest of 2021, with years that start off with five or more deals over $500 million usually driving the outperformance of nearly 4% for the Nasdaq Biotech index, according to JPMorgan’s analysis.\nAs biotech specialists weighed the catalysts for further gains, an 86% jump for Chamath Palihapitiya-backed health insurer Clover drove interest toward once high-flying biotechs with highly shorted floats and mediocre analyst ratings. Inovio Pharmaceuticals Inc., which recently lost U.S. government funding for its Covid shot, and Clovis Oncology Inc., a fallen former M&A target with a disappointing cancer drug, popped this week as day traders targeted short-squeeze candidates.\nRetail traders have also been driving triple-digit and even quadruple-digit gains in obscure biotech names like Ocugen Inc., a drug developer with plans to bring a Covid-19 vaccine to the U.S., and Cassava Sciences Inc., a 20-year old biotech whose main product isn’t yet in the final stages of testing.\nLoncar at least is unfazed by biotechs joining the meme parade. “Professionals understand what the true intrinsic value of a biotech is,” he said in an interview. “Unlike GameStop or AMC, a biotech either has good science or it doesn’t.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186493103,"gmtCreate":1623516837502,"gmtModify":1704205417961,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186493103","repostId":"2142112788","repostType":4,"repost":{"id":"2142112788","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623510300,"share":"https://ttm.financial/m/news/2142112788?lang=&edition=fundamental","pubTime":"2021-06-12 23:05","market":"hk","language":"en","title":"Why direct indexing is gaining traction with financial advisers and their clients","url":"https://stock-news.laohu8.com/highlight/detail?id=2142112788","media":"Dow Jones","summary":"Customized portfolio offers tax and diversification benefits.\n\nAs more investors -- especially young","content":"<blockquote>\n Customized portfolio offers tax and diversification benefits.\n</blockquote>\n<p>As more investors -- especially younger, high-income professionals -- want to hold stocks that they deem socially responsible, they want a customized portfolio that meets their specifications. Through direct indexing, financial advisers can create a basket of individual stocks designed to hew closely to an established index such as the S&amp;P 500 SPX (#phrase-company?ref=COMPANY%7CSPX;onlineSignificance=passing-mention).</p>\n<p>In addition to accommodating clients who want to align their investments with their personal values, there are two other reasons that advisers may offer direct indexing. First, high-net-worth individuals may worry about the tax hit if they sell appreciated stocks. The portfolio optimizer technology that advisers use for direct indexing offers guidance on harvesting tax losses to offset capital gains.</p>\n<p>\"We've had clients who have inherited a portfolio with stocks that produce huge long-term gains,\" said Ken Nuttall, a certified financial planner in West Grove, Pa. \"Direct indexing can help with tax management of inherited assets.\"</p>\n<p>Direct indexing also appeals to clients who have loaded up on their company's stock. Eager to diversify their holdings, they do not want to own other stocks in their industry. So they ask their adviser to track an index like the S&amp;P 500 but without stocks from their employer's sector.</p>\n<p>One downside is that the custom portfolio becomes too independent. \"There is a risk the direct indexing portfolio will deviate from the [benchmark] index,\" said Noah Damsky, a Los Angeles-based adviser. \"The client may be looking to create a tracking error to the upside. But it can lead to a tracking error on the downside.\"</p>\n<p>For many investors, the benefits outweigh that risk. So as long as advisers purchase software that swaps out stocks to advance a client's goals, tailoring portfolios can gain traction.</p>\n<p>\"You'll see more growth in direct indexing in the next year or two,\" Nuttall said. \"Advisers are using it more and appreciating it more.\" The potential for a capital-gains tax increase in the near future adds to the allure of direct indexing. Advisers use the term \"tax alpha\" to describe the process of leveraging tax-saving moves to boost after-tax returns.</p>\n<p>\"Our focus is affluent clients who want us to not just mirror an index but to add tax alpha,\" said Mike Silane, an adviser in Irvine, Calif. \"This is important today, but will be even more important as taxes are likely to rise to pay for today's stimulus and wealthier clients are likely to feel this most.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why direct indexing is gaining traction with financial advisers and their clients</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy direct indexing is gaining traction with financial advisers and their clients\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-12 23:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n Customized portfolio offers tax and diversification benefits.\n</blockquote>\n<p>As more investors -- especially younger, high-income professionals -- want to hold stocks that they deem socially responsible, they want a customized portfolio that meets their specifications. Through direct indexing, financial advisers can create a basket of individual stocks designed to hew closely to an established index such as the S&amp;P 500 SPX (#phrase-company?ref=COMPANY%7CSPX;onlineSignificance=passing-mention).</p>\n<p>In addition to accommodating clients who want to align their investments with their personal values, there are two other reasons that advisers may offer direct indexing. First, high-net-worth individuals may worry about the tax hit if they sell appreciated stocks. The portfolio optimizer technology that advisers use for direct indexing offers guidance on harvesting tax losses to offset capital gains.</p>\n<p>\"We've had clients who have inherited a portfolio with stocks that produce huge long-term gains,\" said Ken Nuttall, a certified financial planner in West Grove, Pa. \"Direct indexing can help with tax management of inherited assets.\"</p>\n<p>Direct indexing also appeals to clients who have loaded up on their company's stock. Eager to diversify their holdings, they do not want to own other stocks in their industry. So they ask their adviser to track an index like the S&amp;P 500 but without stocks from their employer's sector.</p>\n<p>One downside is that the custom portfolio becomes too independent. \"There is a risk the direct indexing portfolio will deviate from the [benchmark] index,\" said Noah Damsky, a Los Angeles-based adviser. \"The client may be looking to create a tracking error to the upside. But it can lead to a tracking error on the downside.\"</p>\n<p>For many investors, the benefits outweigh that risk. So as long as advisers purchase software that swaps out stocks to advance a client's goals, tailoring portfolios can gain traction.</p>\n<p>\"You'll see more growth in direct indexing in the next year or two,\" Nuttall said. \"Advisers are using it more and appreciating it more.\" The potential for a capital-gains tax increase in the near future adds to the allure of direct indexing. Advisers use the term \"tax alpha\" to describe the process of leveraging tax-saving moves to boost after-tax returns.</p>\n<p>\"Our focus is affluent clients who want us to not just mirror an index but to add tax alpha,\" said Mike Silane, an adviser in Irvine, Calif. \"This is important today, but will be even more important as taxes are likely to rise to pay for today's stimulus and wealthier clients are likely to feel this most.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142112788","content_text":"Customized portfolio offers tax and diversification benefits.\n\nAs more investors -- especially younger, high-income professionals -- want to hold stocks that they deem socially responsible, they want a customized portfolio that meets their specifications. Through direct indexing, financial advisers can create a basket of individual stocks designed to hew closely to an established index such as the S&P 500 SPX (#phrase-company?ref=COMPANY%7CSPX;onlineSignificance=passing-mention).\nIn addition to accommodating clients who want to align their investments with their personal values, there are two other reasons that advisers may offer direct indexing. First, high-net-worth individuals may worry about the tax hit if they sell appreciated stocks. The portfolio optimizer technology that advisers use for direct indexing offers guidance on harvesting tax losses to offset capital gains.\n\"We've had clients who have inherited a portfolio with stocks that produce huge long-term gains,\" said Ken Nuttall, a certified financial planner in West Grove, Pa. \"Direct indexing can help with tax management of inherited assets.\"\nDirect indexing also appeals to clients who have loaded up on their company's stock. Eager to diversify their holdings, they do not want to own other stocks in their industry. So they ask their adviser to track an index like the S&P 500 but without stocks from their employer's sector.\nOne downside is that the custom portfolio becomes too independent. \"There is a risk the direct indexing portfolio will deviate from the [benchmark] index,\" said Noah Damsky, a Los Angeles-based adviser. \"The client may be looking to create a tracking error to the upside. But it can lead to a tracking error on the downside.\"\nFor many investors, the benefits outweigh that risk. So as long as advisers purchase software that swaps out stocks to advance a client's goals, tailoring portfolios can gain traction.\n\"You'll see more growth in direct indexing in the next year or two,\" Nuttall said. \"Advisers are using it more and appreciating it more.\" The potential for a capital-gains tax increase in the near future adds to the allure of direct indexing. Advisers use the term \"tax alpha\" to describe the process of leveraging tax-saving moves to boost after-tax returns.\n\"Our focus is affluent clients who want us to not just mirror an index but to add tax alpha,\" said Mike Silane, an adviser in Irvine, Calif. \"This is important today, but will be even more important as taxes are likely to rise to pay for today's stimulus and wealthier clients are likely to feel this most.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186499693,"gmtCreate":1623516745912,"gmtModify":1704205417471,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186499693","repostId":"2142112788","repostType":4,"repost":{"id":"2142112788","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623510300,"share":"https://ttm.financial/m/news/2142112788?lang=&edition=fundamental","pubTime":"2021-06-12 23:05","market":"hk","language":"en","title":"Why direct indexing is gaining traction with financial advisers and their clients","url":"https://stock-news.laohu8.com/highlight/detail?id=2142112788","media":"Dow Jones","summary":"Customized portfolio offers tax and diversification benefits.\n\nAs more investors -- especially young","content":"<blockquote>\n Customized portfolio offers tax and diversification benefits.\n</blockquote>\n<p>As more investors -- especially younger, high-income professionals -- want to hold stocks that they deem socially responsible, they want a customized portfolio that meets their specifications. Through direct indexing, financial advisers can create a basket of individual stocks designed to hew closely to an established index such as the S&amp;P 500 SPX (#phrase-company?ref=COMPANY%7CSPX;onlineSignificance=passing-mention).</p>\n<p>In addition to accommodating clients who want to align their investments with their personal values, there are two other reasons that advisers may offer direct indexing. First, high-net-worth individuals may worry about the tax hit if they sell appreciated stocks. The portfolio optimizer technology that advisers use for direct indexing offers guidance on harvesting tax losses to offset capital gains.</p>\n<p>\"We've had clients who have inherited a portfolio with stocks that produce huge long-term gains,\" said Ken Nuttall, a certified financial planner in West Grove, Pa. \"Direct indexing can help with tax management of inherited assets.\"</p>\n<p>Direct indexing also appeals to clients who have loaded up on their company's stock. Eager to diversify their holdings, they do not want to own other stocks in their industry. So they ask their adviser to track an index like the S&amp;P 500 but without stocks from their employer's sector.</p>\n<p>One downside is that the custom portfolio becomes too independent. \"There is a risk the direct indexing portfolio will deviate from the [benchmark] index,\" said Noah Damsky, a Los Angeles-based adviser. \"The client may be looking to create a tracking error to the upside. But it can lead to a tracking error on the downside.\"</p>\n<p>For many investors, the benefits outweigh that risk. So as long as advisers purchase software that swaps out stocks to advance a client's goals, tailoring portfolios can gain traction.</p>\n<p>\"You'll see more growth in direct indexing in the next year or two,\" Nuttall said. \"Advisers are using it more and appreciating it more.\" The potential for a capital-gains tax increase in the near future adds to the allure of direct indexing. Advisers use the term \"tax alpha\" to describe the process of leveraging tax-saving moves to boost after-tax returns.</p>\n<p>\"Our focus is affluent clients who want us to not just mirror an index but to add tax alpha,\" said Mike Silane, an adviser in Irvine, Calif. \"This is important today, but will be even more important as taxes are likely to rise to pay for today's stimulus and wealthier clients are likely to feel this most.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why direct indexing is gaining traction with financial advisers and their clients</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy direct indexing is gaining traction with financial advisers and their clients\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-12 23:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n Customized portfolio offers tax and diversification benefits.\n</blockquote>\n<p>As more investors -- especially younger, high-income professionals -- want to hold stocks that they deem socially responsible, they want a customized portfolio that meets their specifications. Through direct indexing, financial advisers can create a basket of individual stocks designed to hew closely to an established index such as the S&amp;P 500 SPX (#phrase-company?ref=COMPANY%7CSPX;onlineSignificance=passing-mention).</p>\n<p>In addition to accommodating clients who want to align their investments with their personal values, there are two other reasons that advisers may offer direct indexing. First, high-net-worth individuals may worry about the tax hit if they sell appreciated stocks. The portfolio optimizer technology that advisers use for direct indexing offers guidance on harvesting tax losses to offset capital gains.</p>\n<p>\"We've had clients who have inherited a portfolio with stocks that produce huge long-term gains,\" said Ken Nuttall, a certified financial planner in West Grove, Pa. \"Direct indexing can help with tax management of inherited assets.\"</p>\n<p>Direct indexing also appeals to clients who have loaded up on their company's stock. Eager to diversify their holdings, they do not want to own other stocks in their industry. So they ask their adviser to track an index like the S&amp;P 500 but without stocks from their employer's sector.</p>\n<p>One downside is that the custom portfolio becomes too independent. \"There is a risk the direct indexing portfolio will deviate from the [benchmark] index,\" said Noah Damsky, a Los Angeles-based adviser. \"The client may be looking to create a tracking error to the upside. But it can lead to a tracking error on the downside.\"</p>\n<p>For many investors, the benefits outweigh that risk. So as long as advisers purchase software that swaps out stocks to advance a client's goals, tailoring portfolios can gain traction.</p>\n<p>\"You'll see more growth in direct indexing in the next year or two,\" Nuttall said. \"Advisers are using it more and appreciating it more.\" The potential for a capital-gains tax increase in the near future adds to the allure of direct indexing. Advisers use the term \"tax alpha\" to describe the process of leveraging tax-saving moves to boost after-tax returns.</p>\n<p>\"Our focus is affluent clients who want us to not just mirror an index but to add tax alpha,\" said Mike Silane, an adviser in Irvine, Calif. \"This is important today, but will be even more important as taxes are likely to rise to pay for today's stimulus and wealthier clients are likely to feel this most.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142112788","content_text":"Customized portfolio offers tax and diversification benefits.\n\nAs more investors -- especially younger, high-income professionals -- want to hold stocks that they deem socially responsible, they want a customized portfolio that meets their specifications. Through direct indexing, financial advisers can create a basket of individual stocks designed to hew closely to an established index such as the S&P 500 SPX (#phrase-company?ref=COMPANY%7CSPX;onlineSignificance=passing-mention).\nIn addition to accommodating clients who want to align their investments with their personal values, there are two other reasons that advisers may offer direct indexing. First, high-net-worth individuals may worry about the tax hit if they sell appreciated stocks. The portfolio optimizer technology that advisers use for direct indexing offers guidance on harvesting tax losses to offset capital gains.\n\"We've had clients who have inherited a portfolio with stocks that produce huge long-term gains,\" said Ken Nuttall, a certified financial planner in West Grove, Pa. \"Direct indexing can help with tax management of inherited assets.\"\nDirect indexing also appeals to clients who have loaded up on their company's stock. Eager to diversify their holdings, they do not want to own other stocks in their industry. So they ask their adviser to track an index like the S&P 500 but without stocks from their employer's sector.\nOne downside is that the custom portfolio becomes too independent. \"There is a risk the direct indexing portfolio will deviate from the [benchmark] index,\" said Noah Damsky, a Los Angeles-based adviser. \"The client may be looking to create a tracking error to the upside. But it can lead to a tracking error on the downside.\"\nFor many investors, the benefits outweigh that risk. So as long as advisers purchase software that swaps out stocks to advance a client's goals, tailoring portfolios can gain traction.\n\"You'll see more growth in direct indexing in the next year or two,\" Nuttall said. \"Advisers are using it more and appreciating it more.\" The potential for a capital-gains tax increase in the near future adds to the allure of direct indexing. Advisers use the term \"tax alpha\" to describe the process of leveraging tax-saving moves to boost after-tax returns.\n\"Our focus is affluent clients who want us to not just mirror an index but to add tax alpha,\" said Mike Silane, an adviser in Irvine, Calif. \"This is important today, but will be even more important as taxes are likely to rise to pay for today's stimulus and wealthier clients are likely to feel this most.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186499869,"gmtCreate":1623516733751,"gmtModify":1704205421043,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186499869","repostId":"1189143522","repostType":4,"repost":{"id":"1189143522","pubTimestamp":1623513679,"share":"https://ttm.financial/m/news/1189143522?lang=&edition=fundamental","pubTime":"2021-06-13 00:01","market":"us","language":"en","title":"Snowflake Is a Growth Juggernaut. Wall Street Is Thinking About Stock Value.","url":"https://stock-news.laohu8.com/highlight/detail?id=1189143522","media":"Barron's","summary":"Snowflake remains one of the best growth stories in the history of the software business, and that h","content":"<p>Snowflake remains one of the best growth stories in the history of the software business, and that has Wall Street talking about the stock’s valuation.</p>\n<p>In meeting with analysts on Thursday,the cloud-data software company provided an ambitious goalof reaching $10 billion in product revenue in the January 2029 fiscal year. That compares to $554 million forthe January 2021 fiscal year.</p>\n<p>Snowflake (ticker: SNOW) should still be growing 30% at the top-line at that point, according to chief financial officer Mike Scarpelli, while generating 10% operating margins and free cash flow margins of 15% or better. He also said the company now sees a total addressable market of $90 billion, an expansion of more than 10% from the $81 billion estimated market size cited during its IPO roadshow in 2020.</p>\n<p>The long-term growth goals help frame the huge opportunity that Snowflake has ahead, but did nothing to change the fundamental debate about the stock: Does the impressive growth rate—120% in product revenue in the latest year— justify the massive valuation? In afternoon trading Friday, shares were off 4.4%, to $237.84.</p>\n<p>Canaccord Genuity analyst David Hynes notes that if Snowflake hits its $10 billion target, it would be the fastest that a software company has reached that size. Hynes adds that the history of the management team, led by CEO Frank Slootman, suggests Snowflake could reach its target early.</p>\n<p>But Hynes nonetheless is sticking with his Hold rating and $240 target price. “There’s no doubt that this is an exceptional business, but in our view, the stock’s current valuation”—about 47 times estimated calendar 2022 revenues—“fully reflects it.” He adds that as estimates move higher and the stock grinds sideways, he’s “getting closer to an upgrade,” but isn’t there yet. “We’re content to wait for more of the excess to burn off.”</p>\n<p>Likewise, Morgan Stanley analyst Keith Weiss writes in a research note that given the 120% product growth in fiscal 2021, the $10 billion target might be conservative. He adds that “the harder part of the equation may be justifying the valuation based on these targets.” Weiss says the model that Snowflake laid out implies $1.6 billion in free cash flow in fiscal 2029, which values the stock at 51 times free cash flow 8 years out. “While very impressed by the market opportunity …and Snowflake’s opportunity,” he says valuation keeps him on the sidelines. Weiss repeats his Equal Weigh rating and $270 price target.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Snowflake Is a Growth Juggernaut. Wall Street Is Thinking About Stock Value.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSnowflake Is a Growth Juggernaut. Wall Street Is Thinking About Stock Value.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-13 00:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/snowflake-is-a-growth-juggernaut-wall-street-is-thinking-about-stock-value-51623432689?siteid=yhoof2><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Snowflake remains one of the best growth stories in the history of the software business, and that has Wall Street talking about the stock’s valuation.\nIn meeting with analysts on Thursday,the cloud-...</p>\n\n<a href=\"https://www.barrons.com/articles/snowflake-is-a-growth-juggernaut-wall-street-is-thinking-about-stock-value-51623432689?siteid=yhoof2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNOW":"Snowflake"},"source_url":"https://www.barrons.com/articles/snowflake-is-a-growth-juggernaut-wall-street-is-thinking-about-stock-value-51623432689?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189143522","content_text":"Snowflake remains one of the best growth stories in the history of the software business, and that has Wall Street talking about the stock’s valuation.\nIn meeting with analysts on Thursday,the cloud-data software company provided an ambitious goalof reaching $10 billion in product revenue in the January 2029 fiscal year. That compares to $554 million forthe January 2021 fiscal year.\nSnowflake (ticker: SNOW) should still be growing 30% at the top-line at that point, according to chief financial officer Mike Scarpelli, while generating 10% operating margins and free cash flow margins of 15% or better. He also said the company now sees a total addressable market of $90 billion, an expansion of more than 10% from the $81 billion estimated market size cited during its IPO roadshow in 2020.\nThe long-term growth goals help frame the huge opportunity that Snowflake has ahead, but did nothing to change the fundamental debate about the stock: Does the impressive growth rate—120% in product revenue in the latest year— justify the massive valuation? In afternoon trading Friday, shares were off 4.4%, to $237.84.\nCanaccord Genuity analyst David Hynes notes that if Snowflake hits its $10 billion target, it would be the fastest that a software company has reached that size. Hynes adds that the history of the management team, led by CEO Frank Slootman, suggests Snowflake could reach its target early.\nBut Hynes nonetheless is sticking with his Hold rating and $240 target price. “There’s no doubt that this is an exceptional business, but in our view, the stock’s current valuation”—about 47 times estimated calendar 2022 revenues—“fully reflects it.” He adds that as estimates move higher and the stock grinds sideways, he’s “getting closer to an upgrade,” but isn’t there yet. “We’re content to wait for more of the excess to burn off.”\nLikewise, Morgan Stanley analyst Keith Weiss writes in a research note that given the 120% product growth in fiscal 2021, the $10 billion target might be conservative. He adds that “the harder part of the equation may be justifying the valuation based on these targets.” Weiss says the model that Snowflake laid out implies $1.6 billion in free cash flow in fiscal 2029, which values the stock at 51 times free cash flow 8 years out. “While very impressed by the market opportunity …and Snowflake’s opportunity,” he says valuation keeps him on the sidelines. Weiss repeats his Equal Weigh rating and $270 price target.","news_type":1},"isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186490148,"gmtCreate":1623516629084,"gmtModify":1704205416656,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186490148","repostId":"2142520251","repostType":4,"repost":{"id":"2142520251","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1623444884,"share":"https://ttm.financial/m/news/2142520251?lang=&edition=fundamental","pubTime":"2021-06-12 04:54","market":"hk","language":"en","title":"Sera Prognostics Inc Files For IPO Of Up To $75 Mln Of Class A Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2142520251","media":"T-Reuters","summary":"June 11 (Reuters) - :Sera Prognostics Inc Files For Ipo Of Up To $75 Million Of Class A Common Stock","content":"<p>June 11 (Reuters) - :Sera Prognostics Inc Files For Ipo Of Up To $75 Million Of Class A Common Stock – Sec Filing.Sera Prognostics Inc Says It Intends To Apply To Have Its Class A Common Stock Listed On Nasdaq Global Market Under The Symbol \"Sera\".Sera Prognostics Inc Says Citigroup, Cowen And William Blair Are Underwriters To Ipo.Sera Prognostics Inc Says Laboratory Corp Of America Holdings Beneficially Owned 6.4% Of Class A Comomn Stock Prior To Offering.Sera Prognostics Inc Says Proposed Ipo Price Is An Estimate Solely For Calculating Sec Registration Fee.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sera Prognostics Inc Files For IPO Of Up To $75 Mln Of Class A Common Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSera Prognostics Inc Files For IPO Of Up To $75 Mln Of Class A Common Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-06-12 04:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>June 11 (Reuters) - :Sera Prognostics Inc Files For Ipo Of Up To $75 Million Of Class A Common Stock – Sec Filing.Sera Prognostics Inc Says It Intends To Apply To Have Its Class A Common Stock Listed On Nasdaq Global Market Under The Symbol \"Sera\".Sera Prognostics Inc Says Citigroup, Cowen And William Blair Are Underwriters To Ipo.Sera Prognostics Inc Says Laboratory Corp Of America Holdings Beneficially Owned 6.4% Of Class A Comomn Stock Prior To Offering.Sera Prognostics Inc Says Proposed Ipo Price Is An Estimate Solely For Calculating Sec Registration Fee.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LABP":"Landos Biopharma, Inc.","LHDX":"Lucira Health, Inc.","CGEM":"Cullinan Therapeutics","SANA":"Sana Biotechnology, Inc.","APR":"Apria, Inc.","LH":"徕博科"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142520251","content_text":"June 11 (Reuters) - :Sera Prognostics Inc Files For Ipo Of Up To $75 Million Of Class A Common Stock – Sec Filing.Sera Prognostics Inc Says It Intends To Apply To Have Its Class A Common Stock Listed On Nasdaq Global Market Under The Symbol \"Sera\".Sera Prognostics Inc Says Citigroup, Cowen And William Blair Are Underwriters To Ipo.Sera Prognostics Inc Says Laboratory Corp Of America Holdings Beneficially Owned 6.4% Of Class A Comomn Stock Prior To Offering.Sera Prognostics Inc Says Proposed Ipo Price Is An Estimate Solely For Calculating Sec Registration Fee.","news_type":1},"isVote":1,"tweetType":1,"viewCount":60,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186022634,"gmtCreate":1623466138228,"gmtModify":1704204411378,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186022634","repostId":"1117150461","repostType":4,"repost":{"id":"1117150461","pubTimestamp":1623461758,"share":"https://ttm.financial/m/news/1117150461?lang=&edition=fundamental","pubTime":"2021-06-12 09:35","market":"us","language":"en","title":"Cramer’s week ahead: Don’t underestimate the market’s small gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1117150461","media":"cnbc","summary":"KEY POINTS\n\nCNBC’s Jim Cramer said not to underestimate the small gains stocks have put up in recent","content":"<div>\n<p>KEY POINTS\n\nCNBC’s Jim Cramer said not to underestimate the small gains stocks have put up in recent days.\n“Some would say it’s the calm before the storm ... I learned a long time ago that you never ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/11/cramers-week-ahead-dont-underestimate-the-markets-small-gains.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cramer’s week ahead: Don’t underestimate the market’s small gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCramer’s week ahead: Don’t underestimate the market’s small gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 09:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/11/cramers-week-ahead-dont-underestimate-the-markets-small-gains.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nCNBC’s Jim Cramer said not to underestimate the small gains stocks have put up in recent days.\n“Some would say it’s the calm before the storm ... I learned a long time ago that you never ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/11/cramers-week-ahead-dont-underestimate-the-markets-small-gains.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","SPY":"标普500ETF"},"source_url":"https://www.cnbc.com/2021/06/11/cramers-week-ahead-dont-underestimate-the-markets-small-gains.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1117150461","content_text":"KEY POINTS\n\nCNBC’s Jim Cramer said not to underestimate the small gains stocks have put up in recent days.\n“Some would say it’s the calm before the storm ... I learned a long time ago that you never short a dull market,” the “Mad Money” host said.\n“I want you to find relatively inexpensive stocks of good companies and then you can buy them on the cheap because of this genuine Wall Street gibberish that drives down some stocks unfairly,” he said.\n\nAfter stocks muscled their way slightly higher on Friday, CNBC’s Jim Cramer advised investors not to underestimate a market that’s putting up small gains.\nTheS&P 500crawled 0.19% higher to 4,247.44, a record close.\n“Some would say it’s the calm before the storm ... I learned a long time ago that you never short a dull market,” the “Mad Money” host said. “It’s good news that we’re being lulled to record highs and the market keeps shrugging off negatives, including yesterday’s scorching hot inflation numbers.”\nElsewhere, theDow Jones Industrial Indexinched up 0.04% to 34,479.60. TheNasdaq Compositeincreased 0.35% to settle at 14,069.42.\nIn the week ahead, Wall Street will turn its attentions to producer price index data on Tuesday and a readout from the Federal Reserve’s meeting on Wednesday. The producer price index, which measures how much companies pay producers for goods, could also be hot, Cramer said.\nEither way, investors may be able to find opportunities in the market, he said.\n“I want you to find relatively inexpensive stocks of good companies, and then you can buy them on the cheap because of this genuine Wall Street gibberish that drives down some stocks unfairly,” he said. “Whether they’re value or growth names makes no difference to me or to Cramerica.”\nCramer gave viewers a preview of the upcoming corporate earnings reports he has circled on his calendar. Projections for revenue and earnings per share are based on FactSet estimates:\nTuesday: Oracle\nOracle\n\nQ4 2021 earnings release: after market; conference call: 5 p.m.\nProjected EPS: $1.31\nProjected revenue: $11.02 billion\n\n“This boring, old-school enterprise software company has seen its stock surge 28% year-to-date, thanks to a remarkable acceleration in its core businesses,” Cramer said. “I bet it reports a fine quarter.”\nWednesday: Lennar\nLennar\n\nQ2 2021 earnings release: after market; conference call: Thursday, 10:30 a.m.\nProjected EPS: $2.37\nProjected revenue: $6.10 billion\n\n“Stuart Miller, the former CEO and current executive chairman, likes to give you the state of the state on housing on that conference call,” he said. “We know there’s been an immense amount of inflation in the raw materials that go into a house, although lumber’s come down. But the final cost barely creeps up and that’s thanks to the ingenuity of these excellent builders.”\nThursday: Kroger, Jabil, Adobe\nKroger\n\nQ1 2021 earnings release: before market; conference call: 10 a.m.\nProjected EPS: 98 cents\nProjected revenue: $39.56 billion\n\n“Kroger’s stock has become a standout performer, and that’s because it’s a major beneficiary from inflation,” Cramer said. “I actually do expect a terrific number from Kroger, not many people are thinking that.”\nJabil\n\nQ3 2021 earnings release: before market; conference call: 8:30 a.m.\nProjected EPS: $1.04\nProjected revenue: $6.95 billion\n\n“Jabil does a lot of business with Apple, and Wall Street loves playing silly guessing games by trying to extrapolate from Jabil’s results to Apple’s,” he said. “I wish they’d just focus on Jabil itself, which has been an amazing stock, up 36% for the year. Another unsung stock of an unsung company in an unsung bull market.”\nAdobe\n\nQ2 2021 earnings release: after market; conference call: 5 p.m.\nProjected EPS: $2.81\nProjected revenue: $3.73 billion\n\n“Lately [this] stock’s been meandering and that has usually been the best time to buy it,” the host said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":173,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186088532,"gmtCreate":1623465296526,"gmtModify":1704204380167,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186088532","repostId":"2142204074","repostType":4,"repost":{"id":"2142204074","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623441637,"share":"https://ttm.financial/m/news/2142204074?lang=&edition=fundamental","pubTime":"2021-06-12 04:00","market":"us","language":"en","title":"S&P ekes out gains to close languid week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142204074","media":"Reuters","summary":"NEW YORK, June 11  - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.Economically sensitive smallcaps and transports notched solid gains, outperforming the broader market.For the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.But th","content":"<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P ekes out gains to close languid week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P ekes out gains to close languid week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SQQQ":"纳指三倍做空ETF","DXD":"道指两倍做空ETF","QLD":"纳指两倍做多ETF",".DJI":"道琼斯","PSQ":"纳指反向ETF",".IXIC":"NASDAQ Composite","SDOW":"道指三倍做空ETF-ProShares","DDM":"道指两倍做多ETF",".SPX":"S&P 500 Index","OEX":"标普100","SDS":"两倍做空标普500ETF","TQQQ":"纳指三倍做多ETF","SH":"标普500反向ETF","QQQ":"纳指100ETF","DOG":"道指反向ETF","DJX":"1/100道琼斯","UPRO":"三倍做多标普500ETF","UDOW":"道指三倍做多ETF-ProShares","QID":"纳指两倍做空ETF","IVV":"标普500指数ETF","SSO":"两倍做多标普500ETF","OEF":"标普100指数ETF-iShares","SPXU":"三倍做空标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142204074","content_text":"NEW YORK, June 11 (Reuters) - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.\nEconomically sensitive smallcaps and transports notched solid gains, outperforming the broader market.\nFor the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.\nBut the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.\n\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"\n\"So, investors are going to wait until earnings season.\"\nThe Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.\nInvestors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.\n\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.\nBenchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.\nThe Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's\nAlzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.\nBiogen shares, along with the broader healthcare sector ended the session lower.\nUnofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite added 49.09 points, or 0.35%, to 14,069.42.\nAmong the 11 major sectors in the S&P 500, healthcare suffered the biggest percentage drop.\nMuch of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.\nBut meme stock moves were more muted on Friday, with AMC Entertainment outperforming.\n(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)","news_type":1},"isVote":1,"tweetType":1,"viewCount":65,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":182453087,"gmtCreate":1623600476549,"gmtModify":1704206844463,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"To the moon","listText":"To the moon","text":"To the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/182453087","repostId":"2142202756","repostType":4,"repost":{"id":"2142202756","pubTimestamp":1623449952,"share":"https://ttm.financial/m/news/2142202756?lang=&edition=fundamental","pubTime":"2021-06-12 06:19","market":"us","language":"en","title":"Mudrick’s AMC Bet Backfires After Meme Frenzy Wrecks Hedges","url":"https://stock-news.laohu8.com/highlight/detail?id=2142202756","media":"Bloomberg","summary":"(Bloomberg) -- After weeks of profiting from the stock and debt of AMC Entertainment Holdings Inc., ","content":"<p>(Bloomberg) -- After weeks of profiting from the stock and debt of AMC Entertainment Holdings Inc., hedge fund Mudrick Capital Management ended up with a 5.4% loss after a derivatives bet went haywire.</p>\n<p>The fund, which specializes in distressed debt, suffered the losses on AMC after day traders pushed the movie theater’s shares up as much as 127% on a single day, derailing call options Mudrick had sold on AMC shares to hedge exposure to the company, according to a person with knowledge of the matter. The Wall Street Journal earlier reported on the losses.</p>\n<p>Up until the improbable surge in AMC’s shares, the firm founded by Jason Mudrick had been among the big winners on AMC securities after the hedge fund agreed to help keep the cinema chain afloat last year by committing to buy new debt issued by the company. That and other AMC positions helped the fund reap almost $200 million in gains in January, Bloomberg News previously reported. Then the firm bought about $230 million of new shares from the company in a deal announced June 1, shares it quickly flipped to day traders and other AMC enthusiasts for another profit.</p>\n<p>But that’s when things started to unravel.</p>\n<p>To protect the firm’s holdings from a market plunge, Mudrick sold call options that gave other investors the right to buy shares from him at pre-set levels -- most of which were at $40 or more -- well above any price at which the shares had ever traded.</p>\n<p>As AMC’s stock surged June 2 in its Reddit-fueled frenzy, the price suddenly blasted past the prices at which the fund’s counterparties could cash in on the call options, the person said. The hedges ended up losing 10%, causing the net loss of 5.4%.</p>\n<p>A representative for Mudrick declined to comment.</p>\n<p><b>Shedding Risk</b></p>\n<p>Mudrick no longer has exposure to AMC after unwinding all of its debt, stock and derivatives bets. The firm is still up between 12% and 14% for the year, the person said.</p>\n<p>A risk committee for Mudrick Capital met virtually on the night of June 1 and decided to exit all debt and derivative positions the following day, the person said. Mudrick sold about a third of its exposure before the stock surged even further on June 2 and was fully out by that afternoon. The firm sold its 15% first-lien bonds in the theater chain for 121 cents on the dollar, the person added.</p>\n<p>But the trade’s unwind didn’t come soon enough. AMC shares surged past $40 to reach as high as $72.62, blowing up the firm’s short position and effectively unraveling what had looked like a winning bet.</p>\n<p>AMC shares have soared more than 2,200% this year, and debt holders have also benefited from the rally. The company’s bonds due 2026 that were trading as low as 5 cents on the dollar in November now change hands above face value, according to Trace.</p>\n<p>While ultimately handing Mudrick a loss, the meme stock frenzy helped AMC earn a credit upgrade from S&amp;P Global Ratings after the company was able to raise hundreds of millions of dollars from share sales.</p>\n<p>Mudrick’s flagship fund rose about 12% in 2020, making much of its money in the fourth quarter of last year, Bloomberg previously reported. The firm manages around $3.5 billion.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mudrick’s AMC Bet Backfires After Meme Frenzy Wrecks Hedges</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMudrick’s AMC Bet Backfires After Meme Frenzy Wrecks Hedges\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 06:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/mudrick-amc-bet-backfires-meme-221912972.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- After weeks of profiting from the stock and debt of AMC Entertainment Holdings Inc., hedge fund Mudrick Capital Management ended up with a 5.4% loss after a derivatives bet went haywire...</p>\n\n<a href=\"https://finance.yahoo.com/news/mudrick-amc-bet-backfires-meme-221912972.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://finance.yahoo.com/news/mudrick-amc-bet-backfires-meme-221912972.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142202756","content_text":"(Bloomberg) -- After weeks of profiting from the stock and debt of AMC Entertainment Holdings Inc., hedge fund Mudrick Capital Management ended up with a 5.4% loss after a derivatives bet went haywire.\nThe fund, which specializes in distressed debt, suffered the losses on AMC after day traders pushed the movie theater’s shares up as much as 127% on a single day, derailing call options Mudrick had sold on AMC shares to hedge exposure to the company, according to a person with knowledge of the matter. The Wall Street Journal earlier reported on the losses.\nUp until the improbable surge in AMC’s shares, the firm founded by Jason Mudrick had been among the big winners on AMC securities after the hedge fund agreed to help keep the cinema chain afloat last year by committing to buy new debt issued by the company. That and other AMC positions helped the fund reap almost $200 million in gains in January, Bloomberg News previously reported. Then the firm bought about $230 million of new shares from the company in a deal announced June 1, shares it quickly flipped to day traders and other AMC enthusiasts for another profit.\nBut that’s when things started to unravel.\nTo protect the firm’s holdings from a market plunge, Mudrick sold call options that gave other investors the right to buy shares from him at pre-set levels -- most of which were at $40 or more -- well above any price at which the shares had ever traded.\nAs AMC’s stock surged June 2 in its Reddit-fueled frenzy, the price suddenly blasted past the prices at which the fund’s counterparties could cash in on the call options, the person said. The hedges ended up losing 10%, causing the net loss of 5.4%.\nA representative for Mudrick declined to comment.\nShedding Risk\nMudrick no longer has exposure to AMC after unwinding all of its debt, stock and derivatives bets. The firm is still up between 12% and 14% for the year, the person said.\nA risk committee for Mudrick Capital met virtually on the night of June 1 and decided to exit all debt and derivative positions the following day, the person said. Mudrick sold about a third of its exposure before the stock surged even further on June 2 and was fully out by that afternoon. The firm sold its 15% first-lien bonds in the theater chain for 121 cents on the dollar, the person added.\nBut the trade’s unwind didn’t come soon enough. AMC shares surged past $40 to reach as high as $72.62, blowing up the firm’s short position and effectively unraveling what had looked like a winning bet.\nAMC shares have soared more than 2,200% this year, and debt holders have also benefited from the rally. The company’s bonds due 2026 that were trading as low as 5 cents on the dollar in November now change hands above face value, according to Trace.\nWhile ultimately handing Mudrick a loss, the meme stock frenzy helped AMC earn a credit upgrade from S&P Global Ratings after the company was able to raise hundreds of millions of dollars from share sales.\nMudrick’s flagship fund rose about 12% in 2020, making much of its money in the fourth quarter of last year, Bloomberg previously reported. The firm manages around $3.5 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":325,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186491960,"gmtCreate":1623516908550,"gmtModify":1704205418769,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186491960","repostId":"2142025622","repostType":4,"repost":{"id":"2142025622","pubTimestamp":1623442528,"share":"https://ttm.financial/m/news/2142025622?lang=&edition=fundamental","pubTime":"2021-06-12 04:15","market":"us","language":"en","title":"Biotech Finds Market Love at Last as Meme Traders, FDA Converge","url":"https://stock-news.laohu8.com/highlight/detail?id=2142025622","media":"Bloomberg","summary":"(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial","content":"<p><img src=\"https://static.tigerbbs.com/8cda5e1416d8765a6009019a2442b35a\" tg-width=\"1200\" tg-height=\"675\"></p>\n<p>(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial regulatory decision and a legion of Reddit fans, burning a bunch of short sellers along the way. Now investors are taking a second look at the sector.</p>\n<p>With biotech having trailed the broader market for the past three months and chock full of companies that have been the focus of short sellers, it was catnip for the Reddit crowd. Indeed, the price action wrought havoc across the health-care sector after shorts lost over $465 million on Clover Health Investments Corp. in a single day as the stock nearly doubled.</p>\n<p>The moves weren’t just about amateur traders or punishing the shorts. Specialists who live and breathe biotech received two of three critical updates that have been hailed as the impetus for a broad return of investor interest. That includes approval from the Food and Drug Administration of an Alzheimer’s disease drug from Biogen Inc.</p>\n<p>“One of the clouds overhanging the sector went away this week, it’s a very good sign,” Brad Loncar, chief executive officer of Loncar Investments, said of the FDA decision.</p>\n<p>Monday’s decision by the FDA to approve Aduhelm, the first new medicine for the disease in decades, came despite mixed clinical trials, stunning analysts and buoying the sector. More than 15 million shares in the $11 billion <a href=\"https://laohu8.com/S/EEME\">iShares</a> Nasdaq Biotechnology ETF (IBB) changed hands, the highest daily level since June 2017. The index ended the week up 6%.</p>\n<p>It wasn’t all good news for these drugmakers. Aduhelm’s $56,000 a year price tag and a setback for Vertex Pharmaceuticals Inc. tempered the rally. The cost of the Biogen drug renewed concern about a regulatory clampdown on pricing, while Vertex announced that it had halted development of a liver disease treatment that the company said was unlikely to have a clinical benefit for patients. Shares of the drug developer plunged 11% on Friday and it’s the worst performer among large-cap biotechs, falling 18% so far this year.</p>\n<p>There’s <a href=\"https://laohu8.com/S/AONE\">one</a> more key readout biotech investors are waiting on: results from a trial in major depression from Biogen and its partner <a href=\"https://laohu8.com/S/SAGE\">Sage Therapeutics</a> Inc. With a win for Biogen and a loss for Vertex, the Biogen-Sage results could very well determine which direction biotech goes next, according to RBC analyst Brian Abrahams. The data are expected by the end of June.</p>\n<p>A recent Goldman Sachs survey of 75 investors at the bank’s health-care conference highlights the ongoing uncertainty, with 47% saying the sector would outperform over the second half of the year while the rest were evenly split between expecting health stocks to underperform or move in-line with the broader market.</p>\n<p><b>M&amp;A Hopes</b></p>\n<p>Vertex’s recent failure also came with a silver lining: the potential for a deal to bolster its pipeline. “Management has signaled a new openness to later-stage deals, and the shelving of VX-864 may now force its hand,” Bloomberg Intelligence analyst Marc Engelsgjerd wrote in a note.</p>\n<p>The pace of deals in the first half can determine the direction of biotechs for the rest of 2021, with years that start off with five or more deals over $500 million usually driving the outperformance of nearly 4% for the Nasdaq Biotech index, according to JPMorgan’s analysis.</p>\n<p>As biotech specialists weighed the catalysts for further gains, an 86% jump for Chamath Palihapitiya-backed health insurer Clover drove interest toward once high-flying biotechs with highly shorted floats and mediocre analyst ratings. <a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals Inc</a>., which recently lost U.S. government funding for its Covid shot, and <a href=\"https://laohu8.com/S/CLVS\">Clovis Oncology</a> Inc., a fallen former M&amp;A target with a disappointing cancer drug, popped this week as day traders targeted short-squeeze candidates.</p>\n<p>Retail traders have also been driving triple-digit and even quadruple-digit gains in obscure biotech names like Ocugen Inc., a drug developer with plans to bring a Covid-19 vaccine to the U.S., and <a href=\"https://laohu8.com/S/SAVA\">Cassava Sciences Inc</a>., a 20-year old biotech whose main product isn’t yet in the final stages of testing.</p>\n<p>Loncar at least is unfazed by biotechs joining the meme parade. “Professionals understand what the true intrinsic value of a biotech is,” he said in an interview. “Unlike GameStop or AMC, a biotech either has good science or it doesn’t.”</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biotech Finds Market Love at Last as Meme Traders, FDA Converge</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiotech Finds Market Love at Last as Meme Traders, FDA Converge\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 04:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/biotech-finds-market-love-last-201528495.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial regulatory decision and a legion of Reddit fans, burning a bunch of short sellers along the way. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/biotech-finds-market-love-last-201528495.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRTX":"福泰制药","BIIB":"渤健公司"},"source_url":"https://finance.yahoo.com/news/biotech-finds-market-love-last-201528495.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142025622","content_text":"(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial regulatory decision and a legion of Reddit fans, burning a bunch of short sellers along the way. Now investors are taking a second look at the sector.\nWith biotech having trailed the broader market for the past three months and chock full of companies that have been the focus of short sellers, it was catnip for the Reddit crowd. Indeed, the price action wrought havoc across the health-care sector after shorts lost over $465 million on Clover Health Investments Corp. in a single day as the stock nearly doubled.\nThe moves weren’t just about amateur traders or punishing the shorts. Specialists who live and breathe biotech received two of three critical updates that have been hailed as the impetus for a broad return of investor interest. That includes approval from the Food and Drug Administration of an Alzheimer’s disease drug from Biogen Inc.\n“One of the clouds overhanging the sector went away this week, it’s a very good sign,” Brad Loncar, chief executive officer of Loncar Investments, said of the FDA decision.\nMonday’s decision by the FDA to approve Aduhelm, the first new medicine for the disease in decades, came despite mixed clinical trials, stunning analysts and buoying the sector. More than 15 million shares in the $11 billion iShares Nasdaq Biotechnology ETF (IBB) changed hands, the highest daily level since June 2017. The index ended the week up 6%.\nIt wasn’t all good news for these drugmakers. Aduhelm’s $56,000 a year price tag and a setback for Vertex Pharmaceuticals Inc. tempered the rally. The cost of the Biogen drug renewed concern about a regulatory clampdown on pricing, while Vertex announced that it had halted development of a liver disease treatment that the company said was unlikely to have a clinical benefit for patients. Shares of the drug developer plunged 11% on Friday and it’s the worst performer among large-cap biotechs, falling 18% so far this year.\nThere’s one more key readout biotech investors are waiting on: results from a trial in major depression from Biogen and its partner Sage Therapeutics Inc. With a win for Biogen and a loss for Vertex, the Biogen-Sage results could very well determine which direction biotech goes next, according to RBC analyst Brian Abrahams. The data are expected by the end of June.\nA recent Goldman Sachs survey of 75 investors at the bank’s health-care conference highlights the ongoing uncertainty, with 47% saying the sector would outperform over the second half of the year while the rest were evenly split between expecting health stocks to underperform or move in-line with the broader market.\nM&A Hopes\nVertex’s recent failure also came with a silver lining: the potential for a deal to bolster its pipeline. “Management has signaled a new openness to later-stage deals, and the shelving of VX-864 may now force its hand,” Bloomberg Intelligence analyst Marc Engelsgjerd wrote in a note.\nThe pace of deals in the first half can determine the direction of biotechs for the rest of 2021, with years that start off with five or more deals over $500 million usually driving the outperformance of nearly 4% for the Nasdaq Biotech index, according to JPMorgan’s analysis.\nAs biotech specialists weighed the catalysts for further gains, an 86% jump for Chamath Palihapitiya-backed health insurer Clover drove interest toward once high-flying biotechs with highly shorted floats and mediocre analyst ratings. Inovio Pharmaceuticals Inc., which recently lost U.S. government funding for its Covid shot, and Clovis Oncology Inc., a fallen former M&A target with a disappointing cancer drug, popped this week as day traders targeted short-squeeze candidates.\nRetail traders have also been driving triple-digit and even quadruple-digit gains in obscure biotech names like Ocugen Inc., a drug developer with plans to bring a Covid-19 vaccine to the U.S., and Cassava Sciences Inc., a 20-year old biotech whose main product isn’t yet in the final stages of testing.\nLoncar at least is unfazed by biotechs joining the meme parade. “Professionals understand what the true intrinsic value of a biotech is,” he said in an interview. “Unlike GameStop or AMC, a biotech either has good science or it doesn’t.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182459950,"gmtCreate":1623600433870,"gmtModify":1704206842668,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182459950","repostId":"2142202756","repostType":4,"repost":{"id":"2142202756","pubTimestamp":1623449952,"share":"https://ttm.financial/m/news/2142202756?lang=&edition=fundamental","pubTime":"2021-06-12 06:19","market":"us","language":"en","title":"Mudrick’s AMC Bet Backfires After Meme Frenzy Wrecks Hedges","url":"https://stock-news.laohu8.com/highlight/detail?id=2142202756","media":"Bloomberg","summary":"(Bloomberg) -- After weeks of profiting from the stock and debt of AMC Entertainment Holdings Inc., ","content":"<p>(Bloomberg) -- After weeks of profiting from the stock and debt of AMC Entertainment Holdings Inc., hedge fund Mudrick Capital Management ended up with a 5.4% loss after a derivatives bet went haywire.</p>\n<p>The fund, which specializes in distressed debt, suffered the losses on AMC after day traders pushed the movie theater’s shares up as much as 127% on a single day, derailing call options Mudrick had sold on AMC shares to hedge exposure to the company, according to a person with knowledge of the matter. The Wall Street Journal earlier reported on the losses.</p>\n<p>Up until the improbable surge in AMC’s shares, the firm founded by Jason Mudrick had been among the big winners on AMC securities after the hedge fund agreed to help keep the cinema chain afloat last year by committing to buy new debt issued by the company. That and other AMC positions helped the fund reap almost $200 million in gains in January, Bloomberg News previously reported. Then the firm bought about $230 million of new shares from the company in a deal announced June 1, shares it quickly flipped to day traders and other AMC enthusiasts for another profit.</p>\n<p>But that’s when things started to unravel.</p>\n<p>To protect the firm’s holdings from a market plunge, Mudrick sold call options that gave other investors the right to buy shares from him at pre-set levels -- most of which were at $40 or more -- well above any price at which the shares had ever traded.</p>\n<p>As AMC’s stock surged June 2 in its Reddit-fueled frenzy, the price suddenly blasted past the prices at which the fund’s counterparties could cash in on the call options, the person said. The hedges ended up losing 10%, causing the net loss of 5.4%.</p>\n<p>A representative for Mudrick declined to comment.</p>\n<p><b>Shedding Risk</b></p>\n<p>Mudrick no longer has exposure to AMC after unwinding all of its debt, stock and derivatives bets. The firm is still up between 12% and 14% for the year, the person said.</p>\n<p>A risk committee for Mudrick Capital met virtually on the night of June 1 and decided to exit all debt and derivative positions the following day, the person said. Mudrick sold about a third of its exposure before the stock surged even further on June 2 and was fully out by that afternoon. The firm sold its 15% first-lien bonds in the theater chain for 121 cents on the dollar, the person added.</p>\n<p>But the trade’s unwind didn’t come soon enough. AMC shares surged past $40 to reach as high as $72.62, blowing up the firm’s short position and effectively unraveling what had looked like a winning bet.</p>\n<p>AMC shares have soared more than 2,200% this year, and debt holders have also benefited from the rally. The company’s bonds due 2026 that were trading as low as 5 cents on the dollar in November now change hands above face value, according to Trace.</p>\n<p>While ultimately handing Mudrick a loss, the meme stock frenzy helped AMC earn a credit upgrade from S&amp;P Global Ratings after the company was able to raise hundreds of millions of dollars from share sales.</p>\n<p>Mudrick’s flagship fund rose about 12% in 2020, making much of its money in the fourth quarter of last year, Bloomberg previously reported. The firm manages around $3.5 billion.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mudrick’s AMC Bet Backfires After Meme Frenzy Wrecks Hedges</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMudrick’s AMC Bet Backfires After Meme Frenzy Wrecks Hedges\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 06:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/mudrick-amc-bet-backfires-meme-221912972.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- After weeks of profiting from the stock and debt of AMC Entertainment Holdings Inc., hedge fund Mudrick Capital Management ended up with a 5.4% loss after a derivatives bet went haywire...</p>\n\n<a href=\"https://finance.yahoo.com/news/mudrick-amc-bet-backfires-meme-221912972.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://finance.yahoo.com/news/mudrick-amc-bet-backfires-meme-221912972.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142202756","content_text":"(Bloomberg) -- After weeks of profiting from the stock and debt of AMC Entertainment Holdings Inc., hedge fund Mudrick Capital Management ended up with a 5.4% loss after a derivatives bet went haywire.\nThe fund, which specializes in distressed debt, suffered the losses on AMC after day traders pushed the movie theater’s shares up as much as 127% on a single day, derailing call options Mudrick had sold on AMC shares to hedge exposure to the company, according to a person with knowledge of the matter. The Wall Street Journal earlier reported on the losses.\nUp until the improbable surge in AMC’s shares, the firm founded by Jason Mudrick had been among the big winners on AMC securities after the hedge fund agreed to help keep the cinema chain afloat last year by committing to buy new debt issued by the company. That and other AMC positions helped the fund reap almost $200 million in gains in January, Bloomberg News previously reported. Then the firm bought about $230 million of new shares from the company in a deal announced June 1, shares it quickly flipped to day traders and other AMC enthusiasts for another profit.\nBut that’s when things started to unravel.\nTo protect the firm’s holdings from a market plunge, Mudrick sold call options that gave other investors the right to buy shares from him at pre-set levels -- most of which were at $40 or more -- well above any price at which the shares had ever traded.\nAs AMC’s stock surged June 2 in its Reddit-fueled frenzy, the price suddenly blasted past the prices at which the fund’s counterparties could cash in on the call options, the person said. The hedges ended up losing 10%, causing the net loss of 5.4%.\nA representative for Mudrick declined to comment.\nShedding Risk\nMudrick no longer has exposure to AMC after unwinding all of its debt, stock and derivatives bets. The firm is still up between 12% and 14% for the year, the person said.\nA risk committee for Mudrick Capital met virtually on the night of June 1 and decided to exit all debt and derivative positions the following day, the person said. Mudrick sold about a third of its exposure before the stock surged even further on June 2 and was fully out by that afternoon. The firm sold its 15% first-lien bonds in the theater chain for 121 cents on the dollar, the person added.\nBut the trade’s unwind didn’t come soon enough. AMC shares surged past $40 to reach as high as $72.62, blowing up the firm’s short position and effectively unraveling what had looked like a winning bet.\nAMC shares have soared more than 2,200% this year, and debt holders have also benefited from the rally. The company’s bonds due 2026 that were trading as low as 5 cents on the dollar in November now change hands above face value, according to Trace.\nWhile ultimately handing Mudrick a loss, the meme stock frenzy helped AMC earn a credit upgrade from S&P Global Ratings after the company was able to raise hundreds of millions of dollars from share sales.\nMudrick’s flagship fund rose about 12% in 2020, making much of its money in the fourth quarter of last year, Bloomberg previously reported. The firm manages around $3.5 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182427380,"gmtCreate":1623600335040,"gmtModify":1704206841526,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182427380","repostId":"2142858202","repostType":4,"repost":{"id":"2142858202","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623453060,"share":"https://ttm.financial/m/news/2142858202?lang=&edition=fundamental","pubTime":"2021-06-12 07:11","market":"us","language":"en","title":"Don't be fooled by some of the hawkish sounds coming out of the Fed next week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142858202","media":"Dow Jones","summary":"Fed will remain dovish, economists say.\n\nThere are sixteen different types of hawks found in the Uni","content":"<blockquote>\n Fed will remain dovish, economists say.\n</blockquote>\n<p>There are sixteen different types of hawks found in the United States, according to birdwatchingh.com . While it may be tempting, it is too soon to add Federal Reserve policymakers to that list.</p>\n<p>Much will be made next week out of some potentially \"hawkish\" sounds from the U.S. central bank's policy meeting, economists said, while they stressed that Fed Chairman Jerome Powell and the majority of the voting members of the interest rate setting committee remain \"doves\" and fundamentally will be sticking to their \"patient\" stance on monetary policy.</p>\n<p>\"They are going to be a little bit less dovish than last time,\" said Jim O'Sullivan, chief U.S. macro strategist for TD Securities.</p>\n<p>U.S. inflation has been sizzling in recent months.</p>\n<p>But the recent decline in long-term Treasury yields allows the Fed to lean into the hawkish message, O'Sullivan said.</p>\n<p>While inflation has been surprisingly hot, the Fed \"is willing to wait\" until the fall to see how the labor market responds to the inflation spike, said Ian Shepherdson, chief economist at Pantheon Macroeconomics. Wage pressures play a key role in determining the inflation outlook.</p>\n<p>\"We don't know how many people will come back into the labor market, how participation will rise, and will it be enough to dampen inflationary pressures,\" Shepherdson said.</p>\n<p>\"In the olden days, the Fed would have raised interest rates first and worried about what was going to happen afterwards. But this is a different Fed with a different strategy and a different approach,\" he said.</p>\n<p>The Fed is buying $80 billion of Treasurys and $40 billion of mortgage backed securities each month, along with keeping its benchmark interest rate close to zero, to support the economy.</p>\n<p>The central bank put itself in a bit of a box in December by guiding markets that it wouldn't slow down the pace of purchases until there had been \"substantial further progress\" in its goals of full employment and stable inflation.</p>\n<p><b>What will be the hawkish sounds?</b></p>\n<p>First, the Fed will give in to the reality that talking about tapering the size of its asset purchases makes sense. This is an important shift. Since December, Powell has managed to hold off such talk.</p>\n<p>But this is only the most preliminary of steps.</p>\n<p>Instead \"officials will talk in general straw-poll terms on what principles ought to apply,\" said Lou Crandall, chief economist at Wrightson ICAP.</p>\n<p>It won't be the Fed having a structured debate on a set of options game-planned by the staff. That might happen in July, but not now.</p>\n<p>To downplay the significance, the Fed won't say anything about the \"talks about tapering\" in its formal statement, next Wednesday afternoon, O'Sullivan said.</p>\n<p>Secondly, the Fed's dot-plot, or interest rate forecast chart, may show a shift forward for the first rate hike to come during 2023. At the moment, the Fed shows no rate hikes until 2024 at the earliest.</p>\n<p>At its March meeting, seven out of 18 Fed officials saw a hike before the end of 2023, and it could be nine or ten officials at the June meeting next week.</p>\n<p>Thirdly, the Fed will have to raise its forecast for inflation for this year. In March, the Fed penciled in a 2.2% core rate for the personal consumption expenditure index. While that may rise, the Fed won't move the core rate for 2022 much higher, a signal that it still believes the price gains seen in the last few months reflects \"largely transitory\" factors.</p>\n<p>During press conferences, Powell has said the economy is \"a long way\" from the Fed's goals and it would take \"some time\" for substantial further progress to be achieved.</p>\n<p>\"I wouldn't pound the table and say exactly what Powell is going to say but it is time to start getting away from that language,\" O'Sullivan of TD Securities said.</p>\n<p>At the same time, the Fed has got to say that while the economy has made progress, they still need to see a lot more,\" he added.</p>\n<p>When the Fed added the \"substantial further progress\" guideline, the economy was 9.8 million jobs short of its level in February 2020. At the moment, the economy is 7.6 million jobs short.</p>\n<p>None of these potentially hawkish noises will disturb the central message of Fed officials to the market -- that its benchmark interest rate will stay low next year.</p>\n<p>Even if the Fed starts to taper its asset purchases next January, economists think it will take months before the central bank is ready to take the next step and hike its benchmark interest rates off zero.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Don't be fooled by some of the hawkish sounds coming out of the Fed next week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDon't be fooled by some of the hawkish sounds coming out of the Fed next week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-12 07:11</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n Fed will remain dovish, economists say.\n</blockquote>\n<p>There are sixteen different types of hawks found in the United States, according to birdwatchingh.com . While it may be tempting, it is too soon to add Federal Reserve policymakers to that list.</p>\n<p>Much will be made next week out of some potentially \"hawkish\" sounds from the U.S. central bank's policy meeting, economists said, while they stressed that Fed Chairman Jerome Powell and the majority of the voting members of the interest rate setting committee remain \"doves\" and fundamentally will be sticking to their \"patient\" stance on monetary policy.</p>\n<p>\"They are going to be a little bit less dovish than last time,\" said Jim O'Sullivan, chief U.S. macro strategist for TD Securities.</p>\n<p>U.S. inflation has been sizzling in recent months.</p>\n<p>But the recent decline in long-term Treasury yields allows the Fed to lean into the hawkish message, O'Sullivan said.</p>\n<p>While inflation has been surprisingly hot, the Fed \"is willing to wait\" until the fall to see how the labor market responds to the inflation spike, said Ian Shepherdson, chief economist at Pantheon Macroeconomics. Wage pressures play a key role in determining the inflation outlook.</p>\n<p>\"We don't know how many people will come back into the labor market, how participation will rise, and will it be enough to dampen inflationary pressures,\" Shepherdson said.</p>\n<p>\"In the olden days, the Fed would have raised interest rates first and worried about what was going to happen afterwards. But this is a different Fed with a different strategy and a different approach,\" he said.</p>\n<p>The Fed is buying $80 billion of Treasurys and $40 billion of mortgage backed securities each month, along with keeping its benchmark interest rate close to zero, to support the economy.</p>\n<p>The central bank put itself in a bit of a box in December by guiding markets that it wouldn't slow down the pace of purchases until there had been \"substantial further progress\" in its goals of full employment and stable inflation.</p>\n<p><b>What will be the hawkish sounds?</b></p>\n<p>First, the Fed will give in to the reality that talking about tapering the size of its asset purchases makes sense. This is an important shift. Since December, Powell has managed to hold off such talk.</p>\n<p>But this is only the most preliminary of steps.</p>\n<p>Instead \"officials will talk in general straw-poll terms on what principles ought to apply,\" said Lou Crandall, chief economist at Wrightson ICAP.</p>\n<p>It won't be the Fed having a structured debate on a set of options game-planned by the staff. That might happen in July, but not now.</p>\n<p>To downplay the significance, the Fed won't say anything about the \"talks about tapering\" in its formal statement, next Wednesday afternoon, O'Sullivan said.</p>\n<p>Secondly, the Fed's dot-plot, or interest rate forecast chart, may show a shift forward for the first rate hike to come during 2023. At the moment, the Fed shows no rate hikes until 2024 at the earliest.</p>\n<p>At its March meeting, seven out of 18 Fed officials saw a hike before the end of 2023, and it could be nine or ten officials at the June meeting next week.</p>\n<p>Thirdly, the Fed will have to raise its forecast for inflation for this year. In March, the Fed penciled in a 2.2% core rate for the personal consumption expenditure index. While that may rise, the Fed won't move the core rate for 2022 much higher, a signal that it still believes the price gains seen in the last few months reflects \"largely transitory\" factors.</p>\n<p>During press conferences, Powell has said the economy is \"a long way\" from the Fed's goals and it would take \"some time\" for substantial further progress to be achieved.</p>\n<p>\"I wouldn't pound the table and say exactly what Powell is going to say but it is time to start getting away from that language,\" O'Sullivan of TD Securities said.</p>\n<p>At the same time, the Fed has got to say that while the economy has made progress, they still need to see a lot more,\" he added.</p>\n<p>When the Fed added the \"substantial further progress\" guideline, the economy was 9.8 million jobs short of its level in February 2020. At the moment, the economy is 7.6 million jobs short.</p>\n<p>None of these potentially hawkish noises will disturb the central message of Fed officials to the market -- that its benchmark interest rate will stay low next year.</p>\n<p>Even if the Fed starts to taper its asset purchases next January, economists think it will take months before the central bank is ready to take the next step and hike its benchmark interest rates off zero.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142858202","content_text":"Fed will remain dovish, economists say.\n\nThere are sixteen different types of hawks found in the United States, according to birdwatchingh.com . While it may be tempting, it is too soon to add Federal Reserve policymakers to that list.\nMuch will be made next week out of some potentially \"hawkish\" sounds from the U.S. central bank's policy meeting, economists said, while they stressed that Fed Chairman Jerome Powell and the majority of the voting members of the interest rate setting committee remain \"doves\" and fundamentally will be sticking to their \"patient\" stance on monetary policy.\n\"They are going to be a little bit less dovish than last time,\" said Jim O'Sullivan, chief U.S. macro strategist for TD Securities.\nU.S. inflation has been sizzling in recent months.\nBut the recent decline in long-term Treasury yields allows the Fed to lean into the hawkish message, O'Sullivan said.\nWhile inflation has been surprisingly hot, the Fed \"is willing to wait\" until the fall to see how the labor market responds to the inflation spike, said Ian Shepherdson, chief economist at Pantheon Macroeconomics. Wage pressures play a key role in determining the inflation outlook.\n\"We don't know how many people will come back into the labor market, how participation will rise, and will it be enough to dampen inflationary pressures,\" Shepherdson said.\n\"In the olden days, the Fed would have raised interest rates first and worried about what was going to happen afterwards. But this is a different Fed with a different strategy and a different approach,\" he said.\nThe Fed is buying $80 billion of Treasurys and $40 billion of mortgage backed securities each month, along with keeping its benchmark interest rate close to zero, to support the economy.\nThe central bank put itself in a bit of a box in December by guiding markets that it wouldn't slow down the pace of purchases until there had been \"substantial further progress\" in its goals of full employment and stable inflation.\nWhat will be the hawkish sounds?\nFirst, the Fed will give in to the reality that talking about tapering the size of its asset purchases makes sense. This is an important shift. Since December, Powell has managed to hold off such talk.\nBut this is only the most preliminary of steps.\nInstead \"officials will talk in general straw-poll terms on what principles ought to apply,\" said Lou Crandall, chief economist at Wrightson ICAP.\nIt won't be the Fed having a structured debate on a set of options game-planned by the staff. That might happen in July, but not now.\nTo downplay the significance, the Fed won't say anything about the \"talks about tapering\" in its formal statement, next Wednesday afternoon, O'Sullivan said.\nSecondly, the Fed's dot-plot, or interest rate forecast chart, may show a shift forward for the first rate hike to come during 2023. At the moment, the Fed shows no rate hikes until 2024 at the earliest.\nAt its March meeting, seven out of 18 Fed officials saw a hike before the end of 2023, and it could be nine or ten officials at the June meeting next week.\nThirdly, the Fed will have to raise its forecast for inflation for this year. In March, the Fed penciled in a 2.2% core rate for the personal consumption expenditure index. While that may rise, the Fed won't move the core rate for 2022 much higher, a signal that it still believes the price gains seen in the last few months reflects \"largely transitory\" factors.\nDuring press conferences, Powell has said the economy is \"a long way\" from the Fed's goals and it would take \"some time\" for substantial further progress to be achieved.\n\"I wouldn't pound the table and say exactly what Powell is going to say but it is time to start getting away from that language,\" O'Sullivan of TD Securities said.\nAt the same time, the Fed has got to say that while the economy has made progress, they still need to see a lot more,\" he added.\nWhen the Fed added the \"substantial further progress\" guideline, the economy was 9.8 million jobs short of its level in February 2020. At the moment, the economy is 7.6 million jobs short.\nNone of these potentially hawkish noises will disturb the central message of Fed officials to the market -- that its benchmark interest rate will stay low next year.\nEven if the Fed starts to taper its asset purchases next January, economists think it will take months before the central bank is ready to take the next step and hike its benchmark interest rates off zero.","news_type":1},"isVote":1,"tweetType":1,"viewCount":87,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182424533,"gmtCreate":1623600317322,"gmtModify":1704206840875,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182424533","repostId":"2142878860","repostType":4,"repost":{"id":"2142878860","pubTimestamp":1623502800,"share":"https://ttm.financial/m/news/2142878860?lang=&edition=fundamental","pubTime":"2021-06-12 21:00","market":"us","language":"en","title":"Wannabe Bitcoin ETFs Are Mushrooming and Getting More Creative","url":"https://stock-news.laohu8.com/highlight/detail?id=2142878860","media":"Bloomberg","summary":"(Bloomberg) -- With at least nine applications for Bitcoins ETFs collecting dust in the Securities a","content":"<p><img src=\"https://static.tigerbbs.com/df0e27ba0805faa81349dcd8279cd9d0\" tg-width=\"1200\" tg-height=\"675\"></p>\n<p>(Bloomberg) -- With at least nine applications for Bitcoins ETFs collecting dust in the Securities and Exchange Commission’s in-box and clients baying to buy crypto funds, U.S. issuers in the $6.4 trillion industry are cobbling together a growing number of workarounds.</p>\n<p>A slate of companies are releasing or planning “Bitcoin adjacent” products that skirt U.S. regulators’ refusal to allow the largest cryptocurrency to be put in an exchange-traded fund wrapper. Invesco became the latest on Wednesday, announcing a pair of funds packed with crypto-linked equities.</p>\n<p>It’s the only way U.S. firms can cash in on the unrelenting clamor for digital coins, and it may stay that way for a while. The SEC has already delayed its decision to approve or deny a Bitcoin ETF once this year and is expected to punt again at its next deadline on June 17.</p>\n<p>“There’s clearly strong demand from investors for exposure to the price of Bitcoin, and ETF issuers are simply looking to meet that demand,” said Nate Geraci, president of the ETF Store, an advisory firm. “The SEC is essentially forcing ETF issuers into the laboratory to create these Frankenstein products.”</p>\n<p>The Frankenfunds’ creators are being rewarded for their efforts. For instance, the Bitwise Crypto Industry Innovators ETF (ticker BITQ) has already drawn about $45 million in assets less than a month after its launch. That fund holds crypto-heavy companies like MicroStrategy Inc., Coinbase Global Inc., and Galaxy Digital Holdings Ltd.</p>\n<p>Then there’s a slate of older products finding new life amid the coin craze. The <a href=\"https://laohu8.com/S/BLOK\">Amplify Transformational Data Sharing ETF</a> (BLOK), an actively-managed fund with stocks like MicroStrategy and <a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings Inc., attracted more than $711 million this year already, as its price has risen 30%. A peer fund called the First Trust Indxx Innovative Transaction &amp; Process ETF (LEGR), which invests in companies using or developing blockchain technology, is on pace for its best year of inflows yet.</p>\n<p>“There is a high demand for a Bitcoin product that has all the features that people love about ETFs -- that they trade on an exchange, that they’re liquid,” said Ross Mayfield, investment strategy analyst at Robert W. Baird &amp; Co.</p>\n<p><b>Biggest Player Yet</b></p>\n<p>Invesco is the largest fund manager yet to try the workaround tactic, with its Invesco Galaxy Blockchain Economy ETF and Invesco Galaxy Crypto Economy ETF, each holding about 85% of their assets in crypto-linked equities and the rest in trusts and funds that hold cryptocurrencies.</p>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> days before the Invesco filing, there was an application for the Volt Bitcoin Revolution ETF, which would include companies with Bitcoin exposure. At least 80% of its assets will be in firms that either have Bitcoin on their balance sheet or are developing or using products within the crypto ecosystem, as well as options on those firms and ETFs that have exposure to them.</p>\n<p>More funds tracking the crypto industry -- instead of actual Bitcoin -- may debut in the coming months, as the SEC continues to voice concerns about the market. Recently, SEC Chairman Gary Gensler said the crypto sector could benefit from greater investor protection and has urged Congress to give the regulatory agency authority over trading venues.</p>\n<p>“My optimism on Bitcoin ETF approval has waned recently,” ETF Store’s Geraci said. “It’s hard to view Gensler’s comments on the current state of the Bitcoin and crypto ecosystem and feel optimistic about the prospects of a Bitcoin ETF anytime soon.”</p>\n<p>Even after a true Bitcoin ETF finally launches in U.S. markets, these crypto-flavored funds could still have appeal, especially in a world obsessed with all things involving blockchain and digital tokens.</p>\n<p>“These Bitcoin-adjacent vehicles make sense for people who don’t want to deal with all the volatility of Bitcoin but want exposure,” said Amrita Nandakumar, president of Vident Investment Advisory. “It’s a solution that has popped up in response to the pent-up demand.”</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wannabe Bitcoin ETFs Are Mushrooming and Getting More Creative</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWannabe Bitcoin ETFs Are Mushrooming and Getting More Creative\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 21:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/wannabe-bitcoin-etfs-mushrooming-getting-130000561.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- With at least nine applications for Bitcoins ETFs collecting dust in the Securities and Exchange Commission’s in-box and clients baying to buy crypto funds, U.S. issuers in the $6.4 ...</p>\n\n<a href=\"https://finance.yahoo.com/news/wannabe-bitcoin-etfs-mushrooming-getting-130000561.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IVZ":"美国景顺集团"},"source_url":"https://finance.yahoo.com/news/wannabe-bitcoin-etfs-mushrooming-getting-130000561.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142878860","content_text":"(Bloomberg) -- With at least nine applications for Bitcoins ETFs collecting dust in the Securities and Exchange Commission’s in-box and clients baying to buy crypto funds, U.S. issuers in the $6.4 trillion industry are cobbling together a growing number of workarounds.\nA slate of companies are releasing or planning “Bitcoin adjacent” products that skirt U.S. regulators’ refusal to allow the largest cryptocurrency to be put in an exchange-traded fund wrapper. Invesco became the latest on Wednesday, announcing a pair of funds packed with crypto-linked equities.\nIt’s the only way U.S. firms can cash in on the unrelenting clamor for digital coins, and it may stay that way for a while. The SEC has already delayed its decision to approve or deny a Bitcoin ETF once this year and is expected to punt again at its next deadline on June 17.\n“There’s clearly strong demand from investors for exposure to the price of Bitcoin, and ETF issuers are simply looking to meet that demand,” said Nate Geraci, president of the ETF Store, an advisory firm. “The SEC is essentially forcing ETF issuers into the laboratory to create these Frankenstein products.”\nThe Frankenfunds’ creators are being rewarded for their efforts. For instance, the Bitwise Crypto Industry Innovators ETF (ticker BITQ) has already drawn about $45 million in assets less than a month after its launch. That fund holds crypto-heavy companies like MicroStrategy Inc., Coinbase Global Inc., and Galaxy Digital Holdings Ltd.\nThen there’s a slate of older products finding new life amid the coin craze. The Amplify Transformational Data Sharing ETF (BLOK), an actively-managed fund with stocks like MicroStrategy and PayPal Holdings Inc., attracted more than $711 million this year already, as its price has risen 30%. A peer fund called the First Trust Indxx Innovative Transaction & Process ETF (LEGR), which invests in companies using or developing blockchain technology, is on pace for its best year of inflows yet.\n“There is a high demand for a Bitcoin product that has all the features that people love about ETFs -- that they trade on an exchange, that they’re liquid,” said Ross Mayfield, investment strategy analyst at Robert W. Baird & Co.\nBiggest Player Yet\nInvesco is the largest fund manager yet to try the workaround tactic, with its Invesco Galaxy Blockchain Economy ETF and Invesco Galaxy Crypto Economy ETF, each holding about 85% of their assets in crypto-linked equities and the rest in trusts and funds that hold cryptocurrencies.\nTwo days before the Invesco filing, there was an application for the Volt Bitcoin Revolution ETF, which would include companies with Bitcoin exposure. At least 80% of its assets will be in firms that either have Bitcoin on their balance sheet or are developing or using products within the crypto ecosystem, as well as options on those firms and ETFs that have exposure to them.\nMore funds tracking the crypto industry -- instead of actual Bitcoin -- may debut in the coming months, as the SEC continues to voice concerns about the market. Recently, SEC Chairman Gary Gensler said the crypto sector could benefit from greater investor protection and has urged Congress to give the regulatory agency authority over trading venues.\n“My optimism on Bitcoin ETF approval has waned recently,” ETF Store’s Geraci said. “It’s hard to view Gensler’s comments on the current state of the Bitcoin and crypto ecosystem and feel optimistic about the prospects of a Bitcoin ETF anytime soon.”\nEven after a true Bitcoin ETF finally launches in U.S. markets, these crypto-flavored funds could still have appeal, especially in a world obsessed with all things involving blockchain and digital tokens.\n“These Bitcoin-adjacent vehicles make sense for people who don’t want to deal with all the volatility of Bitcoin but want exposure,” said Amrita Nandakumar, president of Vident Investment Advisory. “It’s a solution that has popped up in response to the pent-up demand.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":149,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182424356,"gmtCreate":1623600300175,"gmtModify":1704206840188,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182424356","repostId":"2142878860","repostType":4,"repost":{"id":"2142878860","pubTimestamp":1623502800,"share":"https://ttm.financial/m/news/2142878860?lang=&edition=fundamental","pubTime":"2021-06-12 21:00","market":"us","language":"en","title":"Wannabe Bitcoin ETFs Are Mushrooming and Getting More Creative","url":"https://stock-news.laohu8.com/highlight/detail?id=2142878860","media":"Bloomberg","summary":"(Bloomberg) -- With at least nine applications for Bitcoins ETFs collecting dust in the Securities a","content":"<p><img src=\"https://static.tigerbbs.com/df0e27ba0805faa81349dcd8279cd9d0\" tg-width=\"1200\" tg-height=\"675\"></p>\n<p>(Bloomberg) -- With at least nine applications for Bitcoins ETFs collecting dust in the Securities and Exchange Commission’s in-box and clients baying to buy crypto funds, U.S. issuers in the $6.4 trillion industry are cobbling together a growing number of workarounds.</p>\n<p>A slate of companies are releasing or planning “Bitcoin adjacent” products that skirt U.S. regulators’ refusal to allow the largest cryptocurrency to be put in an exchange-traded fund wrapper. Invesco became the latest on Wednesday, announcing a pair of funds packed with crypto-linked equities.</p>\n<p>It’s the only way U.S. firms can cash in on the unrelenting clamor for digital coins, and it may stay that way for a while. The SEC has already delayed its decision to approve or deny a Bitcoin ETF once this year and is expected to punt again at its next deadline on June 17.</p>\n<p>“There’s clearly strong demand from investors for exposure to the price of Bitcoin, and ETF issuers are simply looking to meet that demand,” said Nate Geraci, president of the ETF Store, an advisory firm. “The SEC is essentially forcing ETF issuers into the laboratory to create these Frankenstein products.”</p>\n<p>The Frankenfunds’ creators are being rewarded for their efforts. For instance, the Bitwise Crypto Industry Innovators ETF (ticker BITQ) has already drawn about $45 million in assets less than a month after its launch. That fund holds crypto-heavy companies like MicroStrategy Inc., Coinbase Global Inc., and Galaxy Digital Holdings Ltd.</p>\n<p>Then there’s a slate of older products finding new life amid the coin craze. The <a href=\"https://laohu8.com/S/BLOK\">Amplify Transformational Data Sharing ETF</a> (BLOK), an actively-managed fund with stocks like MicroStrategy and <a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings Inc., attracted more than $711 million this year already, as its price has risen 30%. A peer fund called the First Trust Indxx Innovative Transaction &amp; Process ETF (LEGR), which invests in companies using or developing blockchain technology, is on pace for its best year of inflows yet.</p>\n<p>“There is a high demand for a Bitcoin product that has all the features that people love about ETFs -- that they trade on an exchange, that they’re liquid,” said Ross Mayfield, investment strategy analyst at Robert W. Baird &amp; Co.</p>\n<p><b>Biggest Player Yet</b></p>\n<p>Invesco is the largest fund manager yet to try the workaround tactic, with its Invesco Galaxy Blockchain Economy ETF and Invesco Galaxy Crypto Economy ETF, each holding about 85% of their assets in crypto-linked equities and the rest in trusts and funds that hold cryptocurrencies.</p>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> days before the Invesco filing, there was an application for the Volt Bitcoin Revolution ETF, which would include companies with Bitcoin exposure. At least 80% of its assets will be in firms that either have Bitcoin on their balance sheet or are developing or using products within the crypto ecosystem, as well as options on those firms and ETFs that have exposure to them.</p>\n<p>More funds tracking the crypto industry -- instead of actual Bitcoin -- may debut in the coming months, as the SEC continues to voice concerns about the market. Recently, SEC Chairman Gary Gensler said the crypto sector could benefit from greater investor protection and has urged Congress to give the regulatory agency authority over trading venues.</p>\n<p>“My optimism on Bitcoin ETF approval has waned recently,” ETF Store’s Geraci said. “It’s hard to view Gensler’s comments on the current state of the Bitcoin and crypto ecosystem and feel optimistic about the prospects of a Bitcoin ETF anytime soon.”</p>\n<p>Even after a true Bitcoin ETF finally launches in U.S. markets, these crypto-flavored funds could still have appeal, especially in a world obsessed with all things involving blockchain and digital tokens.</p>\n<p>“These Bitcoin-adjacent vehicles make sense for people who don’t want to deal with all the volatility of Bitcoin but want exposure,” said Amrita Nandakumar, president of Vident Investment Advisory. “It’s a solution that has popped up in response to the pent-up demand.”</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wannabe Bitcoin ETFs Are Mushrooming and Getting More Creative</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWannabe Bitcoin ETFs Are Mushrooming and Getting More Creative\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 21:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/wannabe-bitcoin-etfs-mushrooming-getting-130000561.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- With at least nine applications for Bitcoins ETFs collecting dust in the Securities and Exchange Commission’s in-box and clients baying to buy crypto funds, U.S. issuers in the $6.4 ...</p>\n\n<a href=\"https://finance.yahoo.com/news/wannabe-bitcoin-etfs-mushrooming-getting-130000561.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IVZ":"美国景顺集团"},"source_url":"https://finance.yahoo.com/news/wannabe-bitcoin-etfs-mushrooming-getting-130000561.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142878860","content_text":"(Bloomberg) -- With at least nine applications for Bitcoins ETFs collecting dust in the Securities and Exchange Commission’s in-box and clients baying to buy crypto funds, U.S. issuers in the $6.4 trillion industry are cobbling together a growing number of workarounds.\nA slate of companies are releasing or planning “Bitcoin adjacent” products that skirt U.S. regulators’ refusal to allow the largest cryptocurrency to be put in an exchange-traded fund wrapper. Invesco became the latest on Wednesday, announcing a pair of funds packed with crypto-linked equities.\nIt’s the only way U.S. firms can cash in on the unrelenting clamor for digital coins, and it may stay that way for a while. The SEC has already delayed its decision to approve or deny a Bitcoin ETF once this year and is expected to punt again at its next deadline on June 17.\n“There’s clearly strong demand from investors for exposure to the price of Bitcoin, and ETF issuers are simply looking to meet that demand,” said Nate Geraci, president of the ETF Store, an advisory firm. “The SEC is essentially forcing ETF issuers into the laboratory to create these Frankenstein products.”\nThe Frankenfunds’ creators are being rewarded for their efforts. For instance, the Bitwise Crypto Industry Innovators ETF (ticker BITQ) has already drawn about $45 million in assets less than a month after its launch. That fund holds crypto-heavy companies like MicroStrategy Inc., Coinbase Global Inc., and Galaxy Digital Holdings Ltd.\nThen there’s a slate of older products finding new life amid the coin craze. The Amplify Transformational Data Sharing ETF (BLOK), an actively-managed fund with stocks like MicroStrategy and PayPal Holdings Inc., attracted more than $711 million this year already, as its price has risen 30%. A peer fund called the First Trust Indxx Innovative Transaction & Process ETF (LEGR), which invests in companies using or developing blockchain technology, is on pace for its best year of inflows yet.\n“There is a high demand for a Bitcoin product that has all the features that people love about ETFs -- that they trade on an exchange, that they’re liquid,” said Ross Mayfield, investment strategy analyst at Robert W. Baird & Co.\nBiggest Player Yet\nInvesco is the largest fund manager yet to try the workaround tactic, with its Invesco Galaxy Blockchain Economy ETF and Invesco Galaxy Crypto Economy ETF, each holding about 85% of their assets in crypto-linked equities and the rest in trusts and funds that hold cryptocurrencies.\nTwo days before the Invesco filing, there was an application for the Volt Bitcoin Revolution ETF, which would include companies with Bitcoin exposure. At least 80% of its assets will be in firms that either have Bitcoin on their balance sheet or are developing or using products within the crypto ecosystem, as well as options on those firms and ETFs that have exposure to them.\nMore funds tracking the crypto industry -- instead of actual Bitcoin -- may debut in the coming months, as the SEC continues to voice concerns about the market. Recently, SEC Chairman Gary Gensler said the crypto sector could benefit from greater investor protection and has urged Congress to give the regulatory agency authority over trading venues.\n“My optimism on Bitcoin ETF approval has waned recently,” ETF Store’s Geraci said. “It’s hard to view Gensler’s comments on the current state of the Bitcoin and crypto ecosystem and feel optimistic about the prospects of a Bitcoin ETF anytime soon.”\nEven after a true Bitcoin ETF finally launches in U.S. markets, these crypto-flavored funds could still have appeal, especially in a world obsessed with all things involving blockchain and digital tokens.\n“These Bitcoin-adjacent vehicles make sense for people who don’t want to deal with all the volatility of Bitcoin but want exposure,” said Amrita Nandakumar, president of Vident Investment Advisory. “It’s a solution that has popped up in response to the pent-up demand.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182426674,"gmtCreate":1623600210498,"gmtModify":1704206837420,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182426674","repostId":"2142788912","repostType":4,"repost":{"id":"2142788912","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623507814,"share":"https://ttm.financial/m/news/2142788912?lang=&edition=fundamental","pubTime":"2021-06-12 22:23","market":"us","language":"en","title":"Vietnam approves Pfizer/BioNTech COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142788912","media":"Reuters","summary":"HANOI, June 12  - Vietnam has approved the COVID-19 vaccine jointly made by Pfizer and BioNTech for domestic emergency use, the government said on Saturday.It is the fourth vaccine to be endorsed in the Southeast Asian country that is tackling a new outbreak.Vietnam, which has previously approved the AstraZeneca vaccine, Russia's Sputnik V and China's Sinopharm vaccine, said it is seeking to procure 31 million doses of the Pfizer/BioNTech version for delivery in the next quarter.Vietnam is tryin","content":"<p>HANOI, June 12 (Reuters) - Vietnam has approved the COVID-19 vaccine jointly made by Pfizer and BioNTech for domestic emergency use, the government said on Saturday.</p>\n<p>It is the fourth vaccine to be endorsed in the Southeast Asian country that is tackling a new outbreak.</p>\n<p>Vietnam, which has previously approved the AstraZeneca vaccine, Russia's Sputnik V and China's Sinopharm vaccine, said it is seeking to procure 31 million doses of the Pfizer/BioNTech version for delivery in the next quarter.</p>\n<p>Vietnam is trying to accelerate its vaccine procurement drive to tackle a more stubborn wave of infections, even though its overall case load and fatality numbers remain relatively low.</p>\n<p>The health ministry also said on Saturday it was in talks with an unidentified U.S. manufacturer to producer a <a href=\"https://laohu8.com/S/AONE\">one</a>-dose vaccine with a view to producing 100 million-200 million shots per year.</p>\n<p>Vietnam, with a population of around 98 million, has recorded a total of 10,241 coronavirus cases, with 58 deaths, since the pandemic began. Its domestic inoculation started in March.</p>\n<p>At least 1.4 million people in Vietnam have had <a href=\"https://laohu8.com/S/AONE.U\">one</a> dose of a COVID-19 vaccine, while 53,127 have been fully vaccinated, according to official data.</p>\n<p>(Reporting by Phuong Nguyen; Editing by Toby Chopra and Mike Harrison)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vietnam approves Pfizer/BioNTech COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVietnam approves Pfizer/BioNTech COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 22:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HANOI, June 12 (Reuters) - Vietnam has approved the COVID-19 vaccine jointly made by Pfizer and BioNTech for domestic emergency use, the government said on Saturday.</p>\n<p>It is the fourth vaccine to be endorsed in the Southeast Asian country that is tackling a new outbreak.</p>\n<p>Vietnam, which has previously approved the AstraZeneca vaccine, Russia's Sputnik V and China's Sinopharm vaccine, said it is seeking to procure 31 million doses of the Pfizer/BioNTech version for delivery in the next quarter.</p>\n<p>Vietnam is trying to accelerate its vaccine procurement drive to tackle a more stubborn wave of infections, even though its overall case load and fatality numbers remain relatively low.</p>\n<p>The health ministry also said on Saturday it was in talks with an unidentified U.S. manufacturer to producer a <a href=\"https://laohu8.com/S/AONE\">one</a>-dose vaccine with a view to producing 100 million-200 million shots per year.</p>\n<p>Vietnam, with a population of around 98 million, has recorded a total of 10,241 coronavirus cases, with 58 deaths, since the pandemic began. Its domestic inoculation started in March.</p>\n<p>At least 1.4 million people in Vietnam have had <a href=\"https://laohu8.com/S/AONE.U\">one</a> dose of a COVID-19 vaccine, while 53,127 have been fully vaccinated, according to official data.</p>\n<p>(Reporting by Phuong Nguyen; Editing by Toby Chopra and Mike Harrison)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142788912","content_text":"HANOI, June 12 (Reuters) - Vietnam has approved the COVID-19 vaccine jointly made by Pfizer and BioNTech for domestic emergency use, the government said on Saturday.\nIt is the fourth vaccine to be endorsed in the Southeast Asian country that is tackling a new outbreak.\nVietnam, which has previously approved the AstraZeneca vaccine, Russia's Sputnik V and China's Sinopharm vaccine, said it is seeking to procure 31 million doses of the Pfizer/BioNTech version for delivery in the next quarter.\nVietnam is trying to accelerate its vaccine procurement drive to tackle a more stubborn wave of infections, even though its overall case load and fatality numbers remain relatively low.\nThe health ministry also said on Saturday it was in talks with an unidentified U.S. manufacturer to producer a one-dose vaccine with a view to producing 100 million-200 million shots per year.\nVietnam, with a population of around 98 million, has recorded a total of 10,241 coronavirus cases, with 58 deaths, since the pandemic began. Its domestic inoculation started in March.\nAt least 1.4 million people in Vietnam have had one dose of a COVID-19 vaccine, while 53,127 have been fully vaccinated, according to official data.\n(Reporting by Phuong Nguyen; Editing by Toby Chopra and Mike Harrison)","news_type":1},"isVote":1,"tweetType":1,"viewCount":70,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186493103,"gmtCreate":1623516837502,"gmtModify":1704205417961,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186493103","repostId":"2142112788","repostType":4,"repost":{"id":"2142112788","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623510300,"share":"https://ttm.financial/m/news/2142112788?lang=&edition=fundamental","pubTime":"2021-06-12 23:05","market":"hk","language":"en","title":"Why direct indexing is gaining traction with financial advisers and their clients","url":"https://stock-news.laohu8.com/highlight/detail?id=2142112788","media":"Dow Jones","summary":"Customized portfolio offers tax and diversification benefits.\n\nAs more investors -- especially young","content":"<blockquote>\n Customized portfolio offers tax and diversification benefits.\n</blockquote>\n<p>As more investors -- especially younger, high-income professionals -- want to hold stocks that they deem socially responsible, they want a customized portfolio that meets their specifications. Through direct indexing, financial advisers can create a basket of individual stocks designed to hew closely to an established index such as the S&amp;P 500 SPX (#phrase-company?ref=COMPANY%7CSPX;onlineSignificance=passing-mention).</p>\n<p>In addition to accommodating clients who want to align their investments with their personal values, there are two other reasons that advisers may offer direct indexing. First, high-net-worth individuals may worry about the tax hit if they sell appreciated stocks. The portfolio optimizer technology that advisers use for direct indexing offers guidance on harvesting tax losses to offset capital gains.</p>\n<p>\"We've had clients who have inherited a portfolio with stocks that produce huge long-term gains,\" said Ken Nuttall, a certified financial planner in West Grove, Pa. \"Direct indexing can help with tax management of inherited assets.\"</p>\n<p>Direct indexing also appeals to clients who have loaded up on their company's stock. Eager to diversify their holdings, they do not want to own other stocks in their industry. So they ask their adviser to track an index like the S&amp;P 500 but without stocks from their employer's sector.</p>\n<p>One downside is that the custom portfolio becomes too independent. \"There is a risk the direct indexing portfolio will deviate from the [benchmark] index,\" said Noah Damsky, a Los Angeles-based adviser. \"The client may be looking to create a tracking error to the upside. But it can lead to a tracking error on the downside.\"</p>\n<p>For many investors, the benefits outweigh that risk. So as long as advisers purchase software that swaps out stocks to advance a client's goals, tailoring portfolios can gain traction.</p>\n<p>\"You'll see more growth in direct indexing in the next year or two,\" Nuttall said. \"Advisers are using it more and appreciating it more.\" The potential for a capital-gains tax increase in the near future adds to the allure of direct indexing. Advisers use the term \"tax alpha\" to describe the process of leveraging tax-saving moves to boost after-tax returns.</p>\n<p>\"Our focus is affluent clients who want us to not just mirror an index but to add tax alpha,\" said Mike Silane, an adviser in Irvine, Calif. \"This is important today, but will be even more important as taxes are likely to rise to pay for today's stimulus and wealthier clients are likely to feel this most.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why direct indexing is gaining traction with financial advisers and their clients</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy direct indexing is gaining traction with financial advisers and their clients\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-12 23:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n Customized portfolio offers tax and diversification benefits.\n</blockquote>\n<p>As more investors -- especially younger, high-income professionals -- want to hold stocks that they deem socially responsible, they want a customized portfolio that meets their specifications. Through direct indexing, financial advisers can create a basket of individual stocks designed to hew closely to an established index such as the S&amp;P 500 SPX (#phrase-company?ref=COMPANY%7CSPX;onlineSignificance=passing-mention).</p>\n<p>In addition to accommodating clients who want to align their investments with their personal values, there are two other reasons that advisers may offer direct indexing. First, high-net-worth individuals may worry about the tax hit if they sell appreciated stocks. The portfolio optimizer technology that advisers use for direct indexing offers guidance on harvesting tax losses to offset capital gains.</p>\n<p>\"We've had clients who have inherited a portfolio with stocks that produce huge long-term gains,\" said Ken Nuttall, a certified financial planner in West Grove, Pa. \"Direct indexing can help with tax management of inherited assets.\"</p>\n<p>Direct indexing also appeals to clients who have loaded up on their company's stock. Eager to diversify their holdings, they do not want to own other stocks in their industry. So they ask their adviser to track an index like the S&amp;P 500 but without stocks from their employer's sector.</p>\n<p>One downside is that the custom portfolio becomes too independent. \"There is a risk the direct indexing portfolio will deviate from the [benchmark] index,\" said Noah Damsky, a Los Angeles-based adviser. \"The client may be looking to create a tracking error to the upside. But it can lead to a tracking error on the downside.\"</p>\n<p>For many investors, the benefits outweigh that risk. So as long as advisers purchase software that swaps out stocks to advance a client's goals, tailoring portfolios can gain traction.</p>\n<p>\"You'll see more growth in direct indexing in the next year or two,\" Nuttall said. \"Advisers are using it more and appreciating it more.\" The potential for a capital-gains tax increase in the near future adds to the allure of direct indexing. Advisers use the term \"tax alpha\" to describe the process of leveraging tax-saving moves to boost after-tax returns.</p>\n<p>\"Our focus is affluent clients who want us to not just mirror an index but to add tax alpha,\" said Mike Silane, an adviser in Irvine, Calif. \"This is important today, but will be even more important as taxes are likely to rise to pay for today's stimulus and wealthier clients are likely to feel this most.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142112788","content_text":"Customized portfolio offers tax and diversification benefits.\n\nAs more investors -- especially younger, high-income professionals -- want to hold stocks that they deem socially responsible, they want a customized portfolio that meets their specifications. Through direct indexing, financial advisers can create a basket of individual stocks designed to hew closely to an established index such as the S&P 500 SPX (#phrase-company?ref=COMPANY%7CSPX;onlineSignificance=passing-mention).\nIn addition to accommodating clients who want to align their investments with their personal values, there are two other reasons that advisers may offer direct indexing. First, high-net-worth individuals may worry about the tax hit if they sell appreciated stocks. The portfolio optimizer technology that advisers use for direct indexing offers guidance on harvesting tax losses to offset capital gains.\n\"We've had clients who have inherited a portfolio with stocks that produce huge long-term gains,\" said Ken Nuttall, a certified financial planner in West Grove, Pa. \"Direct indexing can help with tax management of inherited assets.\"\nDirect indexing also appeals to clients who have loaded up on their company's stock. Eager to diversify their holdings, they do not want to own other stocks in their industry. So they ask their adviser to track an index like the S&P 500 but without stocks from their employer's sector.\nOne downside is that the custom portfolio becomes too independent. \"There is a risk the direct indexing portfolio will deviate from the [benchmark] index,\" said Noah Damsky, a Los Angeles-based adviser. \"The client may be looking to create a tracking error to the upside. But it can lead to a tracking error on the downside.\"\nFor many investors, the benefits outweigh that risk. So as long as advisers purchase software that swaps out stocks to advance a client's goals, tailoring portfolios can gain traction.\n\"You'll see more growth in direct indexing in the next year or two,\" Nuttall said. \"Advisers are using it more and appreciating it more.\" The potential for a capital-gains tax increase in the near future adds to the allure of direct indexing. Advisers use the term \"tax alpha\" to describe the process of leveraging tax-saving moves to boost after-tax returns.\n\"Our focus is affluent clients who want us to not just mirror an index but to add tax alpha,\" said Mike Silane, an adviser in Irvine, Calif. \"This is important today, but will be even more important as taxes are likely to rise to pay for today's stimulus and wealthier clients are likely to feel this most.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186499693,"gmtCreate":1623516745912,"gmtModify":1704205417471,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186499693","repostId":"2142112788","repostType":4,"repost":{"id":"2142112788","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623510300,"share":"https://ttm.financial/m/news/2142112788?lang=&edition=fundamental","pubTime":"2021-06-12 23:05","market":"hk","language":"en","title":"Why direct indexing is gaining traction with financial advisers and their clients","url":"https://stock-news.laohu8.com/highlight/detail?id=2142112788","media":"Dow Jones","summary":"Customized portfolio offers tax and diversification benefits.\n\nAs more investors -- especially young","content":"<blockquote>\n Customized portfolio offers tax and diversification benefits.\n</blockquote>\n<p>As more investors -- especially younger, high-income professionals -- want to hold stocks that they deem socially responsible, they want a customized portfolio that meets their specifications. Through direct indexing, financial advisers can create a basket of individual stocks designed to hew closely to an established index such as the S&amp;P 500 SPX (#phrase-company?ref=COMPANY%7CSPX;onlineSignificance=passing-mention).</p>\n<p>In addition to accommodating clients who want to align their investments with their personal values, there are two other reasons that advisers may offer direct indexing. First, high-net-worth individuals may worry about the tax hit if they sell appreciated stocks. The portfolio optimizer technology that advisers use for direct indexing offers guidance on harvesting tax losses to offset capital gains.</p>\n<p>\"We've had clients who have inherited a portfolio with stocks that produce huge long-term gains,\" said Ken Nuttall, a certified financial planner in West Grove, Pa. \"Direct indexing can help with tax management of inherited assets.\"</p>\n<p>Direct indexing also appeals to clients who have loaded up on their company's stock. Eager to diversify their holdings, they do not want to own other stocks in their industry. So they ask their adviser to track an index like the S&amp;P 500 but without stocks from their employer's sector.</p>\n<p>One downside is that the custom portfolio becomes too independent. \"There is a risk the direct indexing portfolio will deviate from the [benchmark] index,\" said Noah Damsky, a Los Angeles-based adviser. \"The client may be looking to create a tracking error to the upside. But it can lead to a tracking error on the downside.\"</p>\n<p>For many investors, the benefits outweigh that risk. So as long as advisers purchase software that swaps out stocks to advance a client's goals, tailoring portfolios can gain traction.</p>\n<p>\"You'll see more growth in direct indexing in the next year or two,\" Nuttall said. \"Advisers are using it more and appreciating it more.\" The potential for a capital-gains tax increase in the near future adds to the allure of direct indexing. Advisers use the term \"tax alpha\" to describe the process of leveraging tax-saving moves to boost after-tax returns.</p>\n<p>\"Our focus is affluent clients who want us to not just mirror an index but to add tax alpha,\" said Mike Silane, an adviser in Irvine, Calif. \"This is important today, but will be even more important as taxes are likely to rise to pay for today's stimulus and wealthier clients are likely to feel this most.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why direct indexing is gaining traction with financial advisers and their clients</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy direct indexing is gaining traction with financial advisers and their clients\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-12 23:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n Customized portfolio offers tax and diversification benefits.\n</blockquote>\n<p>As more investors -- especially younger, high-income professionals -- want to hold stocks that they deem socially responsible, they want a customized portfolio that meets their specifications. Through direct indexing, financial advisers can create a basket of individual stocks designed to hew closely to an established index such as the S&amp;P 500 SPX (#phrase-company?ref=COMPANY%7CSPX;onlineSignificance=passing-mention).</p>\n<p>In addition to accommodating clients who want to align their investments with their personal values, there are two other reasons that advisers may offer direct indexing. First, high-net-worth individuals may worry about the tax hit if they sell appreciated stocks. The portfolio optimizer technology that advisers use for direct indexing offers guidance on harvesting tax losses to offset capital gains.</p>\n<p>\"We've had clients who have inherited a portfolio with stocks that produce huge long-term gains,\" said Ken Nuttall, a certified financial planner in West Grove, Pa. \"Direct indexing can help with tax management of inherited assets.\"</p>\n<p>Direct indexing also appeals to clients who have loaded up on their company's stock. Eager to diversify their holdings, they do not want to own other stocks in their industry. So they ask their adviser to track an index like the S&amp;P 500 but without stocks from their employer's sector.</p>\n<p>One downside is that the custom portfolio becomes too independent. \"There is a risk the direct indexing portfolio will deviate from the [benchmark] index,\" said Noah Damsky, a Los Angeles-based adviser. \"The client may be looking to create a tracking error to the upside. But it can lead to a tracking error on the downside.\"</p>\n<p>For many investors, the benefits outweigh that risk. So as long as advisers purchase software that swaps out stocks to advance a client's goals, tailoring portfolios can gain traction.</p>\n<p>\"You'll see more growth in direct indexing in the next year or two,\" Nuttall said. \"Advisers are using it more and appreciating it more.\" The potential for a capital-gains tax increase in the near future adds to the allure of direct indexing. Advisers use the term \"tax alpha\" to describe the process of leveraging tax-saving moves to boost after-tax returns.</p>\n<p>\"Our focus is affluent clients who want us to not just mirror an index but to add tax alpha,\" said Mike Silane, an adviser in Irvine, Calif. \"This is important today, but will be even more important as taxes are likely to rise to pay for today's stimulus and wealthier clients are likely to feel this most.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142112788","content_text":"Customized portfolio offers tax and diversification benefits.\n\nAs more investors -- especially younger, high-income professionals -- want to hold stocks that they deem socially responsible, they want a customized portfolio that meets their specifications. Through direct indexing, financial advisers can create a basket of individual stocks designed to hew closely to an established index such as the S&P 500 SPX (#phrase-company?ref=COMPANY%7CSPX;onlineSignificance=passing-mention).\nIn addition to accommodating clients who want to align their investments with their personal values, there are two other reasons that advisers may offer direct indexing. First, high-net-worth individuals may worry about the tax hit if they sell appreciated stocks. The portfolio optimizer technology that advisers use for direct indexing offers guidance on harvesting tax losses to offset capital gains.\n\"We've had clients who have inherited a portfolio with stocks that produce huge long-term gains,\" said Ken Nuttall, a certified financial planner in West Grove, Pa. \"Direct indexing can help with tax management of inherited assets.\"\nDirect indexing also appeals to clients who have loaded up on their company's stock. Eager to diversify their holdings, they do not want to own other stocks in their industry. So they ask their adviser to track an index like the S&P 500 but without stocks from their employer's sector.\nOne downside is that the custom portfolio becomes too independent. \"There is a risk the direct indexing portfolio will deviate from the [benchmark] index,\" said Noah Damsky, a Los Angeles-based adviser. \"The client may be looking to create a tracking error to the upside. But it can lead to a tracking error on the downside.\"\nFor many investors, the benefits outweigh that risk. So as long as advisers purchase software that swaps out stocks to advance a client's goals, tailoring portfolios can gain traction.\n\"You'll see more growth in direct indexing in the next year or two,\" Nuttall said. \"Advisers are using it more and appreciating it more.\" The potential for a capital-gains tax increase in the near future adds to the allure of direct indexing. Advisers use the term \"tax alpha\" to describe the process of leveraging tax-saving moves to boost after-tax returns.\n\"Our focus is affluent clients who want us to not just mirror an index but to add tax alpha,\" said Mike Silane, an adviser in Irvine, Calif. \"This is important today, but will be even more important as taxes are likely to rise to pay for today's stimulus and wealthier clients are likely to feel this most.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186499869,"gmtCreate":1623516733751,"gmtModify":1704205421043,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186499869","repostId":"1189143522","repostType":4,"repost":{"id":"1189143522","pubTimestamp":1623513679,"share":"https://ttm.financial/m/news/1189143522?lang=&edition=fundamental","pubTime":"2021-06-13 00:01","market":"us","language":"en","title":"Snowflake Is a Growth Juggernaut. Wall Street Is Thinking About Stock Value.","url":"https://stock-news.laohu8.com/highlight/detail?id=1189143522","media":"Barron's","summary":"Snowflake remains one of the best growth stories in the history of the software business, and that h","content":"<p>Snowflake remains one of the best growth stories in the history of the software business, and that has Wall Street talking about the stock’s valuation.</p>\n<p>In meeting with analysts on Thursday,the cloud-data software company provided an ambitious goalof reaching $10 billion in product revenue in the January 2029 fiscal year. That compares to $554 million forthe January 2021 fiscal year.</p>\n<p>Snowflake (ticker: SNOW) should still be growing 30% at the top-line at that point, according to chief financial officer Mike Scarpelli, while generating 10% operating margins and free cash flow margins of 15% or better. He also said the company now sees a total addressable market of $90 billion, an expansion of more than 10% from the $81 billion estimated market size cited during its IPO roadshow in 2020.</p>\n<p>The long-term growth goals help frame the huge opportunity that Snowflake has ahead, but did nothing to change the fundamental debate about the stock: Does the impressive growth rate—120% in product revenue in the latest year— justify the massive valuation? In afternoon trading Friday, shares were off 4.4%, to $237.84.</p>\n<p>Canaccord Genuity analyst David Hynes notes that if Snowflake hits its $10 billion target, it would be the fastest that a software company has reached that size. Hynes adds that the history of the management team, led by CEO Frank Slootman, suggests Snowflake could reach its target early.</p>\n<p>But Hynes nonetheless is sticking with his Hold rating and $240 target price. “There’s no doubt that this is an exceptional business, but in our view, the stock’s current valuation”—about 47 times estimated calendar 2022 revenues—“fully reflects it.” He adds that as estimates move higher and the stock grinds sideways, he’s “getting closer to an upgrade,” but isn’t there yet. “We’re content to wait for more of the excess to burn off.”</p>\n<p>Likewise, Morgan Stanley analyst Keith Weiss writes in a research note that given the 120% product growth in fiscal 2021, the $10 billion target might be conservative. He adds that “the harder part of the equation may be justifying the valuation based on these targets.” Weiss says the model that Snowflake laid out implies $1.6 billion in free cash flow in fiscal 2029, which values the stock at 51 times free cash flow 8 years out. “While very impressed by the market opportunity …and Snowflake’s opportunity,” he says valuation keeps him on the sidelines. Weiss repeats his Equal Weigh rating and $270 price target.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Snowflake Is a Growth Juggernaut. Wall Street Is Thinking About Stock Value.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSnowflake Is a Growth Juggernaut. Wall Street Is Thinking About Stock Value.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-13 00:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/snowflake-is-a-growth-juggernaut-wall-street-is-thinking-about-stock-value-51623432689?siteid=yhoof2><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Snowflake remains one of the best growth stories in the history of the software business, and that has Wall Street talking about the stock’s valuation.\nIn meeting with analysts on Thursday,the cloud-...</p>\n\n<a href=\"https://www.barrons.com/articles/snowflake-is-a-growth-juggernaut-wall-street-is-thinking-about-stock-value-51623432689?siteid=yhoof2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNOW":"Snowflake"},"source_url":"https://www.barrons.com/articles/snowflake-is-a-growth-juggernaut-wall-street-is-thinking-about-stock-value-51623432689?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189143522","content_text":"Snowflake remains one of the best growth stories in the history of the software business, and that has Wall Street talking about the stock’s valuation.\nIn meeting with analysts on Thursday,the cloud-data software company provided an ambitious goalof reaching $10 billion in product revenue in the January 2029 fiscal year. That compares to $554 million forthe January 2021 fiscal year.\nSnowflake (ticker: SNOW) should still be growing 30% at the top-line at that point, according to chief financial officer Mike Scarpelli, while generating 10% operating margins and free cash flow margins of 15% or better. He also said the company now sees a total addressable market of $90 billion, an expansion of more than 10% from the $81 billion estimated market size cited during its IPO roadshow in 2020.\nThe long-term growth goals help frame the huge opportunity that Snowflake has ahead, but did nothing to change the fundamental debate about the stock: Does the impressive growth rate—120% in product revenue in the latest year— justify the massive valuation? In afternoon trading Friday, shares were off 4.4%, to $237.84.\nCanaccord Genuity analyst David Hynes notes that if Snowflake hits its $10 billion target, it would be the fastest that a software company has reached that size. Hynes adds that the history of the management team, led by CEO Frank Slootman, suggests Snowflake could reach its target early.\nBut Hynes nonetheless is sticking with his Hold rating and $240 target price. “There’s no doubt that this is an exceptional business, but in our view, the stock’s current valuation”—about 47 times estimated calendar 2022 revenues—“fully reflects it.” He adds that as estimates move higher and the stock grinds sideways, he’s “getting closer to an upgrade,” but isn’t there yet. “We’re content to wait for more of the excess to burn off.”\nLikewise, Morgan Stanley analyst Keith Weiss writes in a research note that given the 120% product growth in fiscal 2021, the $10 billion target might be conservative. He adds that “the harder part of the equation may be justifying the valuation based on these targets.” Weiss says the model that Snowflake laid out implies $1.6 billion in free cash flow in fiscal 2029, which values the stock at 51 times free cash flow 8 years out. “While very impressed by the market opportunity …and Snowflake’s opportunity,” he says valuation keeps him on the sidelines. Weiss repeats his Equal Weigh rating and $270 price target.","news_type":1},"isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186490148,"gmtCreate":1623516629084,"gmtModify":1704205416656,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186490148","repostId":"2142520251","repostType":4,"repost":{"id":"2142520251","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1623444884,"share":"https://ttm.financial/m/news/2142520251?lang=&edition=fundamental","pubTime":"2021-06-12 04:54","market":"hk","language":"en","title":"Sera Prognostics Inc Files For IPO Of Up To $75 Mln Of Class A Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2142520251","media":"T-Reuters","summary":"June 11 (Reuters) - :Sera Prognostics Inc Files For Ipo Of Up To $75 Million Of Class A Common Stock","content":"<p>June 11 (Reuters) - :Sera Prognostics Inc Files For Ipo Of Up To $75 Million Of Class A Common Stock – Sec Filing.Sera Prognostics Inc Says It Intends To Apply To Have Its Class A Common Stock Listed On Nasdaq Global Market Under The Symbol \"Sera\".Sera Prognostics Inc Says Citigroup, Cowen And William Blair Are Underwriters To Ipo.Sera Prognostics Inc Says Laboratory Corp Of America Holdings Beneficially Owned 6.4% Of Class A Comomn Stock Prior To Offering.Sera Prognostics Inc Says Proposed Ipo Price Is An Estimate Solely For Calculating Sec Registration Fee.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sera Prognostics Inc Files For IPO Of Up To $75 Mln Of Class A Common Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSera Prognostics Inc Files For IPO Of Up To $75 Mln Of Class A Common Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-06-12 04:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>June 11 (Reuters) - :Sera Prognostics Inc Files For Ipo Of Up To $75 Million Of Class A Common Stock – Sec Filing.Sera Prognostics Inc Says It Intends To Apply To Have Its Class A Common Stock Listed On Nasdaq Global Market Under The Symbol \"Sera\".Sera Prognostics Inc Says Citigroup, Cowen And William Blair Are Underwriters To Ipo.Sera Prognostics Inc Says Laboratory Corp Of America Holdings Beneficially Owned 6.4% Of Class A Comomn Stock Prior To Offering.Sera Prognostics Inc Says Proposed Ipo Price Is An Estimate Solely For Calculating Sec Registration Fee.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LABP":"Landos Biopharma, Inc.","LHDX":"Lucira Health, Inc.","CGEM":"Cullinan Therapeutics","SANA":"Sana Biotechnology, Inc.","APR":"Apria, Inc.","LH":"徕博科"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142520251","content_text":"June 11 (Reuters) - :Sera Prognostics Inc Files For Ipo Of Up To $75 Million Of Class A Common Stock – Sec Filing.Sera Prognostics Inc Says It Intends To Apply To Have Its Class A Common Stock Listed On Nasdaq Global Market Under The Symbol \"Sera\".Sera Prognostics Inc Says Citigroup, Cowen And William Blair Are Underwriters To Ipo.Sera Prognostics Inc Says Laboratory Corp Of America Holdings Beneficially Owned 6.4% Of Class A Comomn Stock Prior To Offering.Sera Prognostics Inc Says Proposed Ipo Price Is An Estimate Solely For Calculating Sec Registration Fee.","news_type":1},"isVote":1,"tweetType":1,"viewCount":60,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186022634,"gmtCreate":1623466138228,"gmtModify":1704204411378,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186022634","repostId":"1117150461","repostType":4,"repost":{"id":"1117150461","pubTimestamp":1623461758,"share":"https://ttm.financial/m/news/1117150461?lang=&edition=fundamental","pubTime":"2021-06-12 09:35","market":"us","language":"en","title":"Cramer’s week ahead: Don’t underestimate the market’s small gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1117150461","media":"cnbc","summary":"KEY POINTS\n\nCNBC’s Jim Cramer said not to underestimate the small gains stocks have put up in recent","content":"<div>\n<p>KEY POINTS\n\nCNBC’s Jim Cramer said not to underestimate the small gains stocks have put up in recent days.\n“Some would say it’s the calm before the storm ... I learned a long time ago that you never ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/11/cramers-week-ahead-dont-underestimate-the-markets-small-gains.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cramer’s week ahead: Don’t underestimate the market’s small gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCramer’s week ahead: Don’t underestimate the market’s small gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 09:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/11/cramers-week-ahead-dont-underestimate-the-markets-small-gains.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nCNBC’s Jim Cramer said not to underestimate the small gains stocks have put up in recent days.\n“Some would say it’s the calm before the storm ... I learned a long time ago that you never ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/11/cramers-week-ahead-dont-underestimate-the-markets-small-gains.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","SPY":"标普500ETF"},"source_url":"https://www.cnbc.com/2021/06/11/cramers-week-ahead-dont-underestimate-the-markets-small-gains.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1117150461","content_text":"KEY POINTS\n\nCNBC’s Jim Cramer said not to underestimate the small gains stocks have put up in recent days.\n“Some would say it’s the calm before the storm ... I learned a long time ago that you never short a dull market,” the “Mad Money” host said.\n“I want you to find relatively inexpensive stocks of good companies and then you can buy them on the cheap because of this genuine Wall Street gibberish that drives down some stocks unfairly,” he said.\n\nAfter stocks muscled their way slightly higher on Friday, CNBC’s Jim Cramer advised investors not to underestimate a market that’s putting up small gains.\nTheS&P 500crawled 0.19% higher to 4,247.44, a record close.\n“Some would say it’s the calm before the storm ... I learned a long time ago that you never short a dull market,” the “Mad Money” host said. “It’s good news that we’re being lulled to record highs and the market keeps shrugging off negatives, including yesterday’s scorching hot inflation numbers.”\nElsewhere, theDow Jones Industrial Indexinched up 0.04% to 34,479.60. TheNasdaq Compositeincreased 0.35% to settle at 14,069.42.\nIn the week ahead, Wall Street will turn its attentions to producer price index data on Tuesday and a readout from the Federal Reserve’s meeting on Wednesday. The producer price index, which measures how much companies pay producers for goods, could also be hot, Cramer said.\nEither way, investors may be able to find opportunities in the market, he said.\n“I want you to find relatively inexpensive stocks of good companies, and then you can buy them on the cheap because of this genuine Wall Street gibberish that drives down some stocks unfairly,” he said. “Whether they’re value or growth names makes no difference to me or to Cramerica.”\nCramer gave viewers a preview of the upcoming corporate earnings reports he has circled on his calendar. Projections for revenue and earnings per share are based on FactSet estimates:\nTuesday: Oracle\nOracle\n\nQ4 2021 earnings release: after market; conference call: 5 p.m.\nProjected EPS: $1.31\nProjected revenue: $11.02 billion\n\n“This boring, old-school enterprise software company has seen its stock surge 28% year-to-date, thanks to a remarkable acceleration in its core businesses,” Cramer said. “I bet it reports a fine quarter.”\nWednesday: Lennar\nLennar\n\nQ2 2021 earnings release: after market; conference call: Thursday, 10:30 a.m.\nProjected EPS: $2.37\nProjected revenue: $6.10 billion\n\n“Stuart Miller, the former CEO and current executive chairman, likes to give you the state of the state on housing on that conference call,” he said. “We know there’s been an immense amount of inflation in the raw materials that go into a house, although lumber’s come down. But the final cost barely creeps up and that’s thanks to the ingenuity of these excellent builders.”\nThursday: Kroger, Jabil, Adobe\nKroger\n\nQ1 2021 earnings release: before market; conference call: 10 a.m.\nProjected EPS: 98 cents\nProjected revenue: $39.56 billion\n\n“Kroger’s stock has become a standout performer, and that’s because it’s a major beneficiary from inflation,” Cramer said. “I actually do expect a terrific number from Kroger, not many people are thinking that.”\nJabil\n\nQ3 2021 earnings release: before market; conference call: 8:30 a.m.\nProjected EPS: $1.04\nProjected revenue: $6.95 billion\n\n“Jabil does a lot of business with Apple, and Wall Street loves playing silly guessing games by trying to extrapolate from Jabil’s results to Apple’s,” he said. “I wish they’d just focus on Jabil itself, which has been an amazing stock, up 36% for the year. Another unsung stock of an unsung company in an unsung bull market.”\nAdobe\n\nQ2 2021 earnings release: after market; conference call: 5 p.m.\nProjected EPS: $2.81\nProjected revenue: $3.73 billion\n\n“Lately [this] stock’s been meandering and that has usually been the best time to buy it,” the host said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":173,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186088532,"gmtCreate":1623465296526,"gmtModify":1704204380167,"author":{"id":"3569495193201846","authorId":"3569495193201846","name":"Daren13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569495193201846","authorIdStr":"3569495193201846"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186088532","repostId":"2142204074","repostType":4,"repost":{"id":"2142204074","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623441637,"share":"https://ttm.financial/m/news/2142204074?lang=&edition=fundamental","pubTime":"2021-06-12 04:00","market":"us","language":"en","title":"S&P ekes out gains to close languid week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142204074","media":"Reuters","summary":"NEW YORK, June 11  - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.Economically sensitive smallcaps and transports notched solid gains, outperforming the broader market.For the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.But th","content":"<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P ekes out gains to close languid week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P ekes out gains to close languid week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SQQQ":"纳指三倍做空ETF","DXD":"道指两倍做空ETF","QLD":"纳指两倍做多ETF",".DJI":"道琼斯","PSQ":"纳指反向ETF",".IXIC":"NASDAQ Composite","SDOW":"道指三倍做空ETF-ProShares","DDM":"道指两倍做多ETF",".SPX":"S&P 500 Index","OEX":"标普100","SDS":"两倍做空标普500ETF","TQQQ":"纳指三倍做多ETF","SH":"标普500反向ETF","QQQ":"纳指100ETF","DOG":"道指反向ETF","DJX":"1/100道琼斯","UPRO":"三倍做多标普500ETF","UDOW":"道指三倍做多ETF-ProShares","QID":"纳指两倍做空ETF","IVV":"标普500指数ETF","SSO":"两倍做多标普500ETF","OEF":"标普100指数ETF-iShares","SPXU":"三倍做空标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142204074","content_text":"NEW YORK, June 11 (Reuters) - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.\nEconomically sensitive smallcaps and transports notched solid gains, outperforming the broader market.\nFor the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.\nBut the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.\n\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"\n\"So, investors are going to wait until earnings season.\"\nThe Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.\nInvestors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.\n\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.\nBenchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.\nThe Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's\nAlzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.\nBiogen shares, along with the broader healthcare sector ended the session lower.\nUnofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite added 49.09 points, or 0.35%, to 14,069.42.\nAmong the 11 major sectors in the S&P 500, healthcare suffered the biggest percentage drop.\nMuch of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.\nBut meme stock moves were more muted on Friday, with AMC Entertainment outperforming.\n(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)","news_type":1},"isVote":1,"tweetType":1,"viewCount":65,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}